propranolol has been researched along with Recrudescence in 269 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our primary objective was to review the current use of propranolol for treatment of infantile hemangioma (IH), specifically regarding 1) the age at initiation of therapy, 2) the method of initiation, 3) the use of other adjuvant therapy, 4) the duration of therapy and relapse rate, 5) the adverse events, and 6) the outcome." | 10.25 | Status of propranolol for treatment of infantile hemangioma and description of a randomized clinical trial. ( Bauman, NM; Greene, EA; McCarter, R; Menezes, MD, 2011) |
| "The aim of this study was to compare the recurrence of esophageal varices (EVs) after endoscopic band ligation (EBL) associated with propranolol (PP) versus EBL alone." | 9.20 | Propranolol associated with endoscopic band ligation reduces recurrence of esophageal varices for primary prophylaxis of variceal bleeding: a randomized-controlled trial. ( Bonilha, DQ; Correia, LM; de Paulo, GA; Della Libera, E; Ferrari, AP; Lenz, L; Rodrigues, RA, 2015) |
| "To compare transjugular intrahepatic portosystemic shunt (TIPS) placement with or without variceal embolization with endoscopic band ligation (EBL) plus propranolol in preventing recurrent esophageal variceal bleeding in patients with advanced cirrhosis and portal vein thrombosis." | 9.20 | Advanced Cirrhosis Combined with Portal Vein Thrombosis: A Randomized Trial of TIPS versus Endoscopic Band Ligation Plus Propranolol for the Prevention of Recurrent Esophageal Variceal Bleeding. ( Li, X; Luo, X; Tsauo, J; Wang, Z; Zhang, H; Zhou, B, 2015) |
| "In a multicenter, prospective trial, 62 patients with cirrhosis with high-risk esophageal varices were randomized to propranolol (titrated to reducing resting pulse by > or =25%) or banding (performed monthly until varices were eradicated) and were followed up on the same schedule for a mean duration of 15 months." | 9.11 | Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices. ( Gornbein, J; Han, SH; Jensen, DM; Jutabha, R; Martin, P; Savides, T, 2005) |
| " Forty consecutive patients with bleeding oesophageal varices underwent either injection sclerotherapy only or injection sclerotherapy with an adjuvant fixed daily dose of propranolol (40 mg tds) in a single-blind randomized controlled trial." | 9.11 | Endoscopic sclerotherapy of oesophageal varices due to hepatosplenic schistosomiasis. A randomized controlled trial evaluating the effect of adjuvant propranolol therapy. ( Abdel Baki, M; Dowidar, N; Hafez, A, 2005) |
| "To assess the efficacy of Ligustrazine in combination with propranolol in the prevention of recurrent esophageal varices bleeding following liver cirrhosis, and its act mechanism." | 9.09 | [A randomized controlled study of ligustrazine in combination with propranolol for prevention of recurrent esophageal varices bleeding]. ( Chen, D; Li, X; Zou, J, 2000) |
| "We conducted a prospective, multicenter, randomized trial to compare the efficacy of sclerotherapy plus propranolol with that of propranolol alone in the prevention of recurrent gastroesophageal bleeding in severely cirrhotic patients." | 9.07 | Does elective sclerotherapy improve the efficacy of long-term propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter, randomized trial. ( Anciaux, ML; Ink, O; Labadie, H; Lenoir, C; Marill, JL; Martin, T; Masliah, C; Perrin, D; Poynard, T; Reville, M, 1992) |
| "Forty-one patients admitted with first episode of bleeding from esophageal varices were enrolled in a trial of the efficacy of oral propranolol to prevent rebleeding during the course of endoscopic sclerotherapy until obliteration." | 9.06 | Evaluation of propranolol for prevention of recurrent bleeding from esophageal varices between sclerotherapy sessions. ( Leth, R; Lind, T; Lönroth, H; Lundell, L; Olbe, L; Sjövall, M, 1990) |
| "In 29 patients admitted with their first bleeding episode from oesophageal varices the varices were obliterated within 6 months by treatment with serial endoscopic sclerotherapy and propranolol or with sclerotherapy only." | 9.06 | Propranolol may prevent recurrence of oesophageal varices after obliteration by endoscopic sclerotherapy. ( Jensen, LS; Krarup, N, 1990) |
| "The effect of propranolol on mortality and reinfarction after acute myocardial infarction (AMI) in cigarette smokers and nonsmokers was studied in the Beta Blocker Heart Attack Trial." | 9.06 | Effects of cigarette smoking and propranolol in survivors of acute myocardial infarction. ( Goldstein, S; Jafri, SM; Peters, R; Schultz, LR; Tilley, BC, 1990) |
| "Among the various treatments of ruptured oesophageal varices two seem to be effective: oral propranolol therapy and ligation of the oesophagus on clip." | 9.06 | [Prevention of recurrent hemorrhage caused by the rupture of esophageal varices in cirrhotic patients. A controlled study of propranolol and clip ligation of the esophagus]. ( Ampelas, M; Aubin, JP; Bauret, P; Bories, P; Daures, JP; Feneyrou, B; Guiry, P; Michel, H; Parelon, G; Prioton, JB, 1989) |
| "Thirty-one patients admitted with the first bleeding episode from oesophageal varices were randomized in a double-blind manner to receive oral propranolol, 160 mg daily, for 6 months (n = 15) or matching placebo (n = 16) for the same period." | 9.06 | Propranolol in prevention of rebleeding from oesophageal varices during the course of endoscopic sclerotherapy. ( Jensen, LS; Krarup, N, 1989) |
| "The Beta-Blocker Heart Attack Trial was a multicenter, randomized, double-blind, placebo-controlled trial of propranolol therapy in 3837 men and women with acute myocardial infarction." | 9.05 | Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial. ( Goldstein, S, 1983) |
| "The beta-Blocker Heart Attack Trial (BHAT) was a placebo-controlled, randomized, double-blind clinical trial of the long-term administration of propranolol hydrochloride to persons who had had at least one confirmed myocardial infarction." | 9.05 | A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results. ( , 1983) |
| "Seven patients with chronic or recurrent supraventricular tachyarrhythmias were selected for a trial of antazoline therapy because sinus rhythm or a controlled ventricular response could not be achieved with quinidine, procainamide, digitalis or propranolol." | 9.04 | Antazoline therapy of recurrent refractory supraventricular arrhythmias--a preliminary report. ( Downar, E; Waxman, MB, 1975) |
| "BackgroundPropranolol is the first-choice treatment for severe infantile hemangioma (IH)." | 7.88 | Infantile hemangioma: factors causing recurrence after propranolol treatment. ( Chang, L; Chen, H; Gu, Y; Jin, Y; Lin, X; Lv, D; Ma, G; Qiu, Y; Ying, H; Yu, Z, 2018) |
| " To evaluate the effectiveness, safety and tolerability of propranolol as single-agent treatment in patients with problematic, proliferative-phase, infantile hemangiomas (IHs)." | 7.78 | Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience. ( Georgountzou, A; Kakourou, T; Karavitakis, E; Klimentopoulou, A; Xaidara, A, 2012) |
| "We performed a retrospective chart review with a 6-month follow-up to examine the initial use of propranolol as an adjunctive treatment in children with severe recurrent respiratory papillomatosis." | 7.77 | Initial experience using propranolol as an adjunctive treatment in children with aggressive recurrent respiratory papillomatosis. ( Hartnick, CJ; Kinane, TB; Maturo, S; Tse, SM, 2011) |
| "To determine whether propranolol therapy is safe and effective and superior to oral corticosteroids for treating infantile hemangiomas (IHs)." | 7.77 | Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis. ( Baum, B; Connelly, EA; Duarte, AM; Lattouf, C; McLeod, M; Price, CJ; Schachner, LA, 2011) |
| " Mean percentage of airway obstruction was 68% (15-90) before propranolol introduction." | 7.76 | Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: A preliminary retrospective study of French experience. ( Ayari, S; Carrabin, L; Couloigner, V; Cox, A; Denoyelle, F; Fayoux, P; Froehlich, P; Garabédian, EN; Leboulanger, N; Lescanne, E; Marianowski, R; Marie, JP; Mom, T; Mondain, M; Nicollas, R; Roger, G; Teissier, N; Triglia, JM; Van Den Abbeele, T, 2010) |
| "We determined the clearance of antipyrine before, and during, the administration of propranolol in eight male patients with alcoholic cirrhosis and a recent episode of gastrointestinal bleeding." | 7.66 | Propranolol does not further decrease the clearance of antipyrine in patients with alcoholic cirrhosis. ( Bercoff, E; Larrey, D; Lebrec, D; Pessayre, D, 1983) |
| "Propranolol was administered intravenously to 12 patients with presumed acute myocardial infarction in the attempt to limit infarct size." | 7.66 | Intravenous propranolol therapy for acute myocardial infarction in man: hemodynamic and serial creatine kinase assessment. ( Cairns, JA; Klassen, GA, 1981) |
| "On 51 of 53 occasions, sudden withdrawal of propranolol from patients with angina pectoris produced no substantial adverse effects." | 7.65 | Sudden withdrawal of propranolol in patients with angina pectoris. ( Myers, MG; Wisenberg, G, 1977) |
| "Volume of para-esophageal varices (PEV) correlates with esophageal varices recurrence." | 6.80 | Endoscopic ultrasonography assessment of para-esophageal varices predicts efficacy of propranolol in preventing recurrence of esophageal varices. ( Chang, CJ; Chen, PH; Hou, MC; Lee, FY; Liao, WC; Lin, HC; Su, CW, 2015) |
| "The cause of recurrent bleeding was esophageal varices in nine patients and esophageal ulcers in five patients." | 6.37 | [Sclerotherapy of esophageal varices using ethanol in combination with propranolol: clinical study of 30 patients]. ( Aubert, A; Chaput, JC; Lemman, M; Naveau, S; Poynard, T, 1988) |
| "Our primary objective was to review the current use of propranolol for treatment of infantile hemangioma (IH), specifically regarding 1) the age at initiation of therapy, 2) the method of initiation, 3) the use of other adjuvant therapy, 4) the duration of therapy and relapse rate, 5) the adverse events, and 6) the outcome." | 6.25 | Status of propranolol for treatment of infantile hemangioma and description of a randomized clinical trial. ( Bauman, NM; Greene, EA; McCarter, R; Menezes, MD, 2011) |
| "Infantile hemangiomas are the most common vascular tumors in childhood." | 5.42 | Delayed-onset of multiple cutaneous infantile hemangiomas due to propranolol: a case report. ( del Boz González, J; Navarro Morón, J; Porcel Chacón, R, 2015) |
| "Cirrhosis recurrence is frequent after orthotopic liver transplantation for hepatitis C virus (HCV)." | 5.39 | Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control study. ( Abraldes, JG; Berzigotti, A; Bosch, J; Carrión, JA; Forns, X; García-Pagán, JC; García-Valdecasas, JC; Navasa, M; Schepis, F; Vukotic, R, 2013) |
| "100) rebled from esophageal varices within a mean time of 8." | 5.27 | [Propranolol prevention of hemorrhagic recurrence caused by rupture of esophageal varices: worsened prognosis in ascites and jaundice]. ( Attali, P; Buffet, C; Etienne, JP; Ink, O; Pelletier, G; Servent, L, 1985) |
| "The aim of this study was to compare the recurrence of esophageal varices (EVs) after endoscopic band ligation (EBL) associated with propranolol (PP) versus EBL alone." | 5.20 | Propranolol associated with endoscopic band ligation reduces recurrence of esophageal varices for primary prophylaxis of variceal bleeding: a randomized-controlled trial. ( Bonilha, DQ; Correia, LM; de Paulo, GA; Della Libera, E; Ferrari, AP; Lenz, L; Rodrigues, RA, 2015) |
| "To compare transjugular intrahepatic portosystemic shunt (TIPS) placement with or without variceal embolization with endoscopic band ligation (EBL) plus propranolol in preventing recurrent esophageal variceal bleeding in patients with advanced cirrhosis and portal vein thrombosis." | 5.20 | Advanced Cirrhosis Combined with Portal Vein Thrombosis: A Randomized Trial of TIPS versus Endoscopic Band Ligation Plus Propranolol for the Prevention of Recurrent Esophageal Variceal Bleeding. ( Li, X; Luo, X; Tsauo, J; Wang, Z; Zhang, H; Zhou, B, 2015) |
| "In a multicenter, prospective trial, 62 patients with cirrhosis with high-risk esophageal varices were randomized to propranolol (titrated to reducing resting pulse by > or =25%) or banding (performed monthly until varices were eradicated) and were followed up on the same schedule for a mean duration of 15 months." | 5.11 | Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices. ( Gornbein, J; Han, SH; Jensen, DM; Jutabha, R; Martin, P; Savides, T, 2005) |
| " Forty consecutive patients with bleeding oesophageal varices underwent either injection sclerotherapy only or injection sclerotherapy with an adjuvant fixed daily dose of propranolol (40 mg tds) in a single-blind randomized controlled trial." | 5.11 | Endoscopic sclerotherapy of oesophageal varices due to hepatosplenic schistosomiasis. A randomized controlled trial evaluating the effect of adjuvant propranolol therapy. ( Abdel Baki, M; Dowidar, N; Hafez, A, 2005) |
| "We compared propranolol therapy and endoscopic ligation for the primary prevention of bleeding from esophageal varices." | 5.09 | Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. ( Kumar, M; Lamba, GS; Misra, A; Murthy, NS; Sarin, SK, 1999) |
| "To assess the efficacy of Ligustrazine in combination with propranolol in the prevention of recurrent esophageal varices bleeding following liver cirrhosis, and its act mechanism." | 5.09 | [A randomized controlled study of ligustrazine in combination with propranolol for prevention of recurrent esophageal varices bleeding]. ( Chen, D; Li, X; Zou, J, 2000) |
| "Band ligation of esophageal varices may accentuate gastropathy, which in this study was partly relieved by propranolol." | 5.09 | The effects of endoscopic variceal ligation and propranolol on portal hypertensive gastropathy: a prospective, controlled trial. ( Chen, TA; Cheng, JS; Chiang, HT; Hsu, PI; Lai, KH; Lin, CK; Lo, GH; Wang, EM, 2001) |
| "To compare endoscopic sclerotherapy, propranolol and distal splenorenal shunt in the prevention of rebleeding esophageal varices and mortality in alcoholic cirrhotics." | 5.08 | Prevention of recurrent esophageal bleeding and survival in patients with alcoholic cirrhosis: a randomized study. ( Castro, F; Marquez, E; Medina, R; Molina, A; Oharriz, J; Rubio, CE; Torres, EA; Urbistondo, M, 1996) |
| "A prospective randomized double-blind study was conducted to evaluate the efficacy of propranolol in patients with portal hypertension undergoing long-term endoscopic sclerotherapy (EST) for recurrent variceal bleeding." | 5.07 | A prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy. ( Acharya, SK; Dasarathy, S; Pande, JN; Saksena, S, 1993) |
| "We conducted a prospective, multicenter, randomized trial to compare the efficacy of sclerotherapy plus propranolol with that of propranolol alone in the prevention of recurrent gastroesophageal bleeding in severely cirrhotic patients." | 5.07 | Does elective sclerotherapy improve the efficacy of long-term propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter, randomized trial. ( Anciaux, ML; Ink, O; Labadie, H; Lenoir, C; Marill, JL; Martin, T; Masliah, C; Perrin, D; Poynard, T; Reville, M, 1992) |
| "Forty-one patients admitted with first episode of bleeding from esophageal varices were enrolled in a trial of the efficacy of oral propranolol to prevent rebleeding during the course of endoscopic sclerotherapy until obliteration." | 5.06 | Evaluation of propranolol for prevention of recurrent bleeding from esophageal varices between sclerotherapy sessions. ( Leth, R; Lind, T; Lönroth, H; Lundell, L; Olbe, L; Sjövall, M, 1990) |
| "In 29 patients admitted with their first bleeding episode from oesophageal varices the varices were obliterated within 6 months by treatment with serial endoscopic sclerotherapy and propranolol or with sclerotherapy only." | 5.06 | Propranolol may prevent recurrence of oesophageal varices after obliteration by endoscopic sclerotherapy. ( Jensen, LS; Krarup, N, 1990) |
| "The effect of propranolol on mortality and reinfarction after acute myocardial infarction (AMI) in cigarette smokers and nonsmokers was studied in the Beta Blocker Heart Attack Trial." | 5.06 | Effects of cigarette smoking and propranolol in survivors of acute myocardial infarction. ( Goldstein, S; Jafri, SM; Peters, R; Schultz, LR; Tilley, BC, 1990) |
| "Among the various treatments of ruptured oesophageal varices two seem to be effective: oral propranolol therapy and ligation of the oesophagus on clip." | 5.06 | [Prevention of recurrent hemorrhage caused by the rupture of esophageal varices in cirrhotic patients. A controlled study of propranolol and clip ligation of the esophagus]. ( Ampelas, M; Aubin, JP; Bauret, P; Bories, P; Daures, JP; Feneyrou, B; Guiry, P; Michel, H; Parelon, G; Prioton, JB, 1989) |
| "Thirty-one patients admitted with the first bleeding episode from oesophageal varices were randomized in a double-blind manner to receive oral propranolol, 160 mg daily, for 6 months (n = 15) or matching placebo (n = 16) for the same period." | 5.06 | Propranolol in prevention of rebleeding from oesophageal varices during the course of endoscopic sclerotherapy. ( Jensen, LS; Krarup, N, 1989) |
| "In the Beta Blocker Heart Attack Trial, a double blind, randomized, controlled study, patients taking propranolol (180 or 240 mg/day) initiated 5-21 days post myocardial infarction had 26% fewer deaths than those taking placebo over a 25 month (mean) followup." | 5.06 | Mortality in the beta blocker heart attack trial: circumstances surrounding death. ( Arensberg, D; Barker, A; Byington, R; Friedman, LM; Goldstein, S; Laubach, C; Peters, RW; Romhilt, DW; Wilner, GW, 1987) |
| "The Beta Blocker Heart Attack Trial (BHAT) is a multicenter, randomized, double-blind, placebo control clinical trial sponsored by the National Heart, Lung, and Blood Institute designed to test the effectiveness of regular propranolol administration in reducing total mortality in patients who have survived a recent acute myocardial infarction." | 5.05 | Beta Blocker Heart Attack Trial: design features. ( , 1981) |
| "Recently completed Beta-Blocker Heart Attack Trial in which propranolol was administered to patients following an acute myocardial infarction resulted in a 26% decrease in total mortality and a 23% decrease in total coronary events in the propranolol-treated patients as compared to the placebo patients during the average follow-up of 25 months." | 5.05 | The Beta-Blocker Heart Attack Trial in perspective. ( Goldstein, S, 1983) |
| "The Beta-Blocker Heart Attack Trial was a randomized double blind controlled trial comparing propranolol with placebo in 3837 patients with a recent myocardial infarction." | 5.05 | Statistical aspects of early termination in the beta-blocker heart attack trial. ( DeMets, DL; Friedman, LM; Hardy, R; Lan, KK, 1984) |
| "The Beta-Blocker Heart Attack Trial (BHAT) was a multicentered, double-blind, randomized, placebo-controlled clinical trial designed to test the efficacy of long-term therapy with propranolol given to survivors of an acute myocardial infarction (MI)." | 5.05 | Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research group. ( Byington, RP, 1984) |
| "The Beta-Blocker Heart Attack Trial was a multicenter, randomized, double-blind, placebo-controlled trial of propranolol therapy in 3837 men and women with acute myocardial infarction." | 5.05 | Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial. ( Goldstein, S, 1983) |
| "The beta-Blocker Heart Attack Trial (BHAT) was a placebo-controlled, randomized, double-blind clinical trial of the long-term administration of propranolol hydrochloride to persons who had had at least one confirmed myocardial infarction." | 5.05 | A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results. ( , 1983) |
| "Seven patients with chronic or recurrent supraventricular tachyarrhythmias were selected for a trial of antazoline therapy because sinus rhythm or a controlled ventricular response could not be achieved with quinidine, procainamide, digitalis or propranolol." | 5.04 | Antazoline therapy of recurrent refractory supraventricular arrhythmias--a preliminary report. ( Downar, E; Waxman, MB, 1975) |
| "BackgroundPropranolol is the first-choice treatment for severe infantile hemangioma (IH)." | 3.88 | Infantile hemangioma: factors causing recurrence after propranolol treatment. ( Chang, L; Chen, H; Gu, Y; Jin, Y; Lin, X; Lv, D; Ma, G; Qiu, Y; Ying, H; Yu, Z, 2018) |
| "A relapse into nicotine addiction during abstinence often occurs after the reactivation of nicotine reward memories, either by acute exposure to nicotine (a smoking episode) or by smoking-associated conditioned stimuli (CS)." | 3.85 | Effect of Selective Inhibition of Reactivated Nicotine-Associated Memories With Propranolol on Nicotine Craving. ( Bao, YP; Chen, YY; Deng, JH; Huang, GD; Lu, L; Luo, YX; Shaham, Y; Shi, J; Wang, YM; Wu, P; Xue, YX; Zhang, LB, 2017) |
| " Sixteen patients had recrudescence of IH off-treatment, with propranolol discontinued at a median age of 14 months (interquartile range 10-15 months)." | 3.80 | Retrospective analysis of beta-blocker instituted for treatment of hemangiomas (RABBIT study). ( Castelo-Soccio, L; Chu, DH; Gelfand, JM; Perman, MJ; Shaddy, RE; Shah, KN; Treat, JR; Wan, J; Yan, AC, 2014) |
| "The aim of this study was to describe the results of endoscopic secondary prophylaxis, alone or in combination with propranolol, used to prevent upper gastrointestinal bleeding (UGIB) in children and adolescents with esophageal varices." | 3.79 | Endoscopic and pharmacological secondary prophylaxis in children and adolescents with esophageal varices. ( Bittencourt, PF; Carvalho, SD; dos Santos, JM; Fagundes, ED; Ferreira, AP; Ferreira, AR; Ferreira, LS; Figueiredo Filho, PP; Magalhães, MC; Penna, FJ, 2013) |
| " To evaluate the effectiveness, safety and tolerability of propranolol as single-agent treatment in patients with problematic, proliferative-phase, infantile hemangiomas (IHs)." | 3.78 | Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience. ( Georgountzou, A; Kakourou, T; Karavitakis, E; Klimentopoulou, A; Xaidara, A, 2012) |
| "We performed a retrospective chart review with a 6-month follow-up to examine the initial use of propranolol as an adjunctive treatment in children with severe recurrent respiratory papillomatosis." | 3.77 | Initial experience using propranolol as an adjunctive treatment in children with aggressive recurrent respiratory papillomatosis. ( Hartnick, CJ; Kinane, TB; Maturo, S; Tse, SM, 2011) |
| "To determine whether propranolol therapy is safe and effective and superior to oral corticosteroids for treating infantile hemangiomas (IHs)." | 3.77 | Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis. ( Baum, B; Connelly, EA; Duarte, AM; Lattouf, C; McLeod, M; Price, CJ; Schachner, LA, 2011) |
| "The modal migraine sufferer treated in these studies was a female, about 37 years of age, who suffered from common (rather than classical) migraines and reported a 17-year history of problem migraines." | 3.77 | Propranolol in the management of recurrent migraine: a meta-analytic review. ( Cordingley, GE; Holroyd, KA; Penzien, DB, 1991) |
| " Mean percentage of airway obstruction was 68% (15-90) before propranolol introduction." | 3.76 | Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: A preliminary retrospective study of French experience. ( Ayari, S; Carrabin, L; Couloigner, V; Cox, A; Denoyelle, F; Fayoux, P; Froehlich, P; Garabédian, EN; Leboulanger, N; Lescanne, E; Marianowski, R; Marie, JP; Mom, T; Mondain, M; Nicollas, R; Roger, G; Teissier, N; Triglia, JM; Van Den Abbeele, T, 2010) |
| "Patients with abdominal migraine may benefit from prophylactic treatment with propranolol or cyproheptadine." | 3.70 | Abdominal migraine: prophylactic treatment and follow-up. ( Lichtman, SN; Rhoads, JM; Ulshen, MH; Worawattanakul, M, 1999) |
| "The effect of a single dose of nifedipine or propranolol hydrochloride on gastric acid production and motility has been assessed in 90 duodenal ulcer (DU) patients having the relapse." | 3.69 | [The effect of calcium antagonists and beta-adrenoblockaders on disordered stomach functions in patients with duodenal peptic ulcer]. ( Budnik, IuB; Syman, LN; Tsimmerman, IaS, 1994) |
| " We describe a 72-year-old lady who initially presented with episodic hypoglycemia secondary to an insulinoma that was controlled by diazoxide." | 3.69 | Relapse of medically treated insulinoma following the development of thyrotoxicosis: an assessment of potential mechanisms. ( Alberti, KG; Kendall-Taylor, P; Trajano, LR; Walker, M, 1994) |
| "Paired bicycle ergometry [correction of veloergometric] testing was carried out in 94 patients with a history of myocardial infarction before and after single intakes of 40 mg of obsidan and 200 mg of labetalol." | 3.68 | [The use of labetalol and propranolol in patients who have had a myocardial infarct]. ( Babov, KD; Il'iash, MG; Kravtsova, LA; Shcherbak, IaIu, 1990) |
| "The effectiveness of oral propranolol and sclerotherapy in preventing recurrent bleeding after an endoscopically proven haemorrhage from oesophageal varices was compared in Pugh's grade B and C patients divided into two successive therapeutic groups." | 3.67 | [Prevention of hemorrhagic recurrence in cirrhotic patients. Is sclerotherapy better than propranolol?]. ( Attali, P; Buffet, C; Etienne, JP; Fritsch, J; Honein, K; Ink, O; Pelletier, G, 1988) |
| "We determined the clearance of antipyrine before, and during, the administration of propranolol in eight male patients with alcoholic cirrhosis and a recent episode of gastrointestinal bleeding." | 3.66 | Propranolol does not further decrease the clearance of antipyrine in patients with alcoholic cirrhosis. ( Bercoff, E; Larrey, D; Lebrec, D; Pessayre, D, 1983) |
| "Propranolol was administered intravenously to 12 patients with presumed acute myocardial infarction in the attempt to limit infarct size." | 3.66 | Intravenous propranolol therapy for acute myocardial infarction in man: hemodynamic and serial creatine kinase assessment. ( Cairns, JA; Klassen, GA, 1981) |
| "On 51 of 53 occasions, sudden withdrawal of propranolol from patients with angina pectoris produced no substantial adverse effects." | 3.65 | Sudden withdrawal of propranolol in patients with angina pectoris. ( Myers, MG; Wisenberg, G, 1977) |
| " Lidocaine was effective in terminating acute symptomatic attacks; procaine amide and propranolol were effective in long-term control of the arrhythmia." | 3.65 | Idiopathic paroxysmal ventricular tachycardia in infants and children. ( Goldring, D; Hernandez, A; Kleiger, RE; Strauss, A, 1975) |
| " In 78 per cent of the cases, atrial fibrillation recurred by the end of 12 months in spite of the administration of quinidine or procainamide or propranolol, singly or combined." | 3.65 | Maintenance of sinus rhythm after atrial defibrillation. ( Batson, GA; Sideris, DA; Szekely, P, 1970) |
| "Volume of para-esophageal varices (PEV) correlates with esophageal varices recurrence." | 2.80 | Endoscopic ultrasonography assessment of para-esophageal varices predicts efficacy of propranolol in preventing recurrence of esophageal varices. ( Chang, CJ; Chen, PH; Hou, MC; Lee, FY; Liao, WC; Lin, HC; Su, CW, 2015) |
| "Rosacea is a chronic skin disease of unknown etiology, affecting the central areas of the face skin (cheeks, chin, nose, forehead) and is characterized by periods of remission and exacerbation." | 2.78 | [New possibilities in the treatment of early stages of rosacea]. ( Katsitadze, A; Tsiskarishvili, NV; Tsiskarishvili, Ts, 2013) |
| " Time to recurrence and adverse events were secondary outcomes." | 2.77 | The study of antiarrhythmic medications in infancy (SAMIS): a multicenter, randomized controlled trial comparing the efficacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants. ( Anderson, CC; Bar-Cohen, Y; Batra, AS; Blaufox, AD; Etheridge, SP; Fournier, A; Gibbs, KA; Kanter, RJ; Mackie, AS; McCrindle, BW; Potts, JE; Reed, JH; Ro, PS; Ross, BA; Sanatani, S; Saul, JP; Singh, HR; Stephenson, EA; Tisma-Dupanovic, S; Wong, KK, 2012) |
| "Primary end points were recurrence of variceal bleeding or death." | 2.75 | Equal efficacy of endoscopic variceal ligation and propranolol in preventing variceal bleeding in patients with noncirrhotic portal hypertension. ( Agrawal, A; Gupta, N; Jha, SK; Kumar, A; Mishra, SR; Sarin, SK; Sharma, BC, 2010) |
| "Bleeding from gastric varices is often severe and difficult to manage." | 2.75 | Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial. ( Chander Sharma, B; Kumar, A; Mishra, SR; Sarin, SK, 2010) |
| "In patients with neurocardiogenic syncope, head-up tilt often evokes acute loss of consciousness accompanied by vasodilatation, increased plasma adrenaline and systemic hypotension." | 2.72 | Failure of propranolol to prevent tilt-evoked systemic vasodilatation, adrenaline release and neurocardiogenic syncope. ( Eldadah, BA; Goldstein, DS; Holmes, CS; Moak, JP; Pechnik, SL; Saleem, AM, 2006) |
| "The obliteration of esophageal and/or gastric varices using Histoacryl is highly effective in controlling active bleeding." | 2.71 | Endoscopic histoacryl obliteration vs. propranolol in the prevention of esophagogastric variceal rebleeding: a randomized trial. ( Delhaye, M; Devière, J; Dumonceau, JM; Evrard, S; Golstein, P; Le Moine, O, 2003) |
| "The incidence of clinically significant hepatic encephalopathy after 1 year was higher in the shunt group (36% vs 18%, p = 0." | 2.68 | Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. ( Blum, HE; Deibert, P; Geiger, R; Haag, K; Hauenstein, KH; Keller, W; Ochs, A; Olschewski, M; Rössle, M; Siegerstetter, V; Stiepak, C, 1997) |
| "Hepatic encephalopathy was observed in 29% of the patients in the TIPS group and in 13% of those in the ES group (P = 0." | 2.68 | Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. ( Benz, C; Richter, GM; Sauer, P; Stiehl, A; Stremmel, W; Theilmann, L, 1997) |
| " The present study was aimed at comparing the efficacy of endoscopic sclerotherapy and long-term administration of propranolol in the prevention of rebleeding and long-term survival in patients who had bled from varices." | 2.67 | Propranolol versus sclerotherapy in preventing variceal rebleeding: a randomized controlled trial. ( Bordas, JM; Bosch, J; Cirera, I; Feu, F; Garcia Pagán, JC; Rodés, J; Terés, J, 1993) |
| "Propranolol was given orally twice a day until heart rate was reduced by 25% in the resting position." | 2.67 | Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial. ( Avgerinos, A; Gouma, P; Klonis, C; Papadimitriou, N; Pournaras, S; Raptis, S; Rekoumis, G, 1993) |
| "Bleeding recurrence was less frequent in the treated patients (Kaplan Meier analysis p < 0." | 2.67 | [Prevention of digestive hemorrhage recurrence in hepatic cirrhosis with propranolol. A 4 years' follow-up study]. ( Armas, R; Jirón, MI; Soto, JR; Wolff, C, 1993) |
| "Propranolol dose was adjusted to reduce the resting heart rate by 25% of the basal value (mean +/- SD, 194." | 2.67 | Endoscopic sclerotherapy versus propranolol in prevention of recurrent variceal bleeding in patients with child's B and C cirrhosis: a preliminary report. ( Bhargava, DK; Dwivedi, M; Ramachandran, K, 1992) |
| "When considering only rebleedings from esophageal varices, 4 patients rebled in group 2 vs." | 2.67 | Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliteration. ( Barjonet, G; Barjonnet, G; Cales, P; Combis, JM; Desmorat, H; Lamouliatte, H; Pradere, B; Quinton, A; Roux, D; Vinel, JP, 1992) |
| "Propranolol-treated patients had fewer episodes of acute bleeding than controls (0." | 2.67 | Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. ( Bosch, J; González, A; Panés, J; Pérez, R; Pérez-Ayuso, RM; Piqué, JM; Quintero, E; Rigau, J; Valderrama, R; Viver, J, 1991) |
| "A trend toward decreased recurrence of unstable angina was present in the surgery group at 1 year (six of 168 [3." | 2.67 | Quality of life after bypass surgery for unstable angina. 5-year follow-up results of a Veterans Affairs Cooperative Study. ( Booth, DC; DeMaria, AN; Deupree, RH; Hultgren, HN; Luchi, RJ; Scott, SM, 1991) |
| "Propranolol was given twice daily with a mean final dose of 54 +/- 16 mg/day, this resulted in a mean reduction in resting heart rate of 26 +/- 7%." | 2.67 | Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapy. ( Boyer, J; Burtin, P; Calès, P; Charneau, J; D'Aubigny, N; Joubaud, F; Person, B; Pujol, P; Rossi, V; Valentin, S, 1991) |
| "The placebo arm of the Beta-Blocker Heart Attack Trial (BHAT) provides a unique opportunity to compare the long-term cardiac events in patients suffering from their first and uncomplicated Q wave or non-Q wave AMI." | 2.67 | Natural history of the first non-Q wave myocardial infarction in the placebo arm of the Beta-Blocker Heart Attack Trial. ( Gheorghiade, M; Goldstein, S; Kao, W; Schultz, L; Tilley, B, 1991) |
| " Patients were chosen randomly to receive oral propranolol (in a dosage to reduce resting pulse rate by 25%) or to undergo long-term injection sclerotherapy." | 2.67 | A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of variceal bleeding. ( Gimson, AE; Hayes, PC; Hayllar, K; Polson, RJ; Westaby, D; Williams, R, 1990) |
| "Study endpoints were severe recurrence of variceal hemorrhage or death." | 2.67 | Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic patients. A controlled trial. ( Birnie, GG; Carter, DC; Garden, OJ; Mills, PR; Murray, GD, 1990) |
| "Atenolol was given at a fixed dose of 100 mg per day." | 2.66 | Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial. ( Colombo, M; de Franchis, R; Dioguardi, N; Sangiovanni, A; Tommasini, M, 1989) |
| "This may in turn depend on the recurrence of bleeding." | 2.66 | Reduction in early recurrence of variceal bleeding by propranolol. ( Beglinger, C; Bögtlin, J; Gyr, KE; Kiowski, W; Loosli, J; Marbet, UA; Ritz, R; Schaub, N; Stalder, GA; Straumann, A, 1988) |
| "Patients with a history of venous thrombosis and mutations in genes encoding for coagulation factors (factor V Leiden, factor II, G20210A) do not have an enhanced risk of recurrence and, thus, do not qualify for extended secondary thromboprophylaxis." | 2.42 | The risk of recurrent venous thromboembolism: the Austrian Study on Recurrent Venous Thromboembolism. ( Eichinger, S; Kyrle, PA, 2003) |
| "Terlipressin has longer effects and is more effective and safer than vasopressin alone or in combination with nitroglycerin." | 2.41 | The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage. ( Bosch, J, 2000) |
| "Propranolol was the most effective agent with reported benefit in four of six cases, other antimigraine agents were deemed effective in two of seven cases." | 2.39 | Prophylactic therapy in cyclic vomiting syndrome. ( Forbes, D; Withers, G, 1995) |
| "Bleeding from esophagogastric varices carries a high mortality rate." | 2.38 | Bleeding esophagogastric varices. Ways to treat active episodes and prevent recurrence. ( Marshall, JB, 1991) |
| "In the patient with cardiac arrest related to transient myocardial ischemia, a direct approach toward relieving ischemia seems appropriate." | 2.37 | Considerations in the long-term management of survivors of cardiac arrest. ( Cobb, LA; Greene, HL; Hallstrom, AP; Trobaugh, GB; Weaver, WD, 1984) |
| "Headache is a common chronic and recurrent symptom in children and adolescents." | 2.37 | Chronic and recurrent headaches in children and adolescents. ( Gascon, GG, 1984) |
| "The cause of recurrent bleeding was esophageal varices in nine patients and esophageal ulcers in five patients." | 2.37 | [Sclerotherapy of esophageal varices using ethanol in combination with propranolol: clinical study of 30 patients]. ( Aubert, A; Chaput, JC; Lemman, M; Naveau, S; Poynard, T, 1988) |
| "Peptic ulcer disease, oesophageal varices and Mallory-Weiss tear are the major causes." | 2.36 | Management of upper gastrointestinal haemorrhage. ( Korman, MG, 1983) |
| "No recurrence was reported in any of the patients who achieved complete resolution after 3 months of follow-up." | 1.62 | Topical β-blockers for pyogenic granulomas: A promising option for younger patients. ( Al-Refaie, AAA; El-Taweel, AEI; Salem, KHA; Salem, RM, 2021) |
| "A mouse model of endometriosis recurrence caused by spillage and dissemination was first established using 24 female Balb/c mice." | 1.62 | Preoperative and perioperative intervention reduces the risk of recurrence of endometriosis in mice caused by either incomplete excision or spillage and dissemination. ( Chen, Y; Guo, SW; Liu, X, 2021) |
| "On-treatment recurrence was observed in 30." | 1.56 | Experience using propranolol for the management of supraventricular tachycardia in patients younger than 1 year. ( Abello, MS; Díaz, CJ; Doiny, DG; Falconi, EC; Majdalani, MG; Moltedo, JM; Nicastro, ES, 2020) |
| "Propranolol treatment had no effect on consolidation of extinction learning, but impaired reconsolidation of self-administration." | 1.48 | Noradrenergic β-receptor antagonism in the basolateral amygdala impairs reconsolidation, but not extinction, of alcohol self-administration: Intra-BLA propranolol impairs reconsolidation of alcohol self-administration. ( Chesworth, R; Corbit, LH, 2018) |
| "Propranolol therapy was considered successful when patients were initiated and discharged on monotherapy, without documented recurrence of arrhythmia or requiring additional antiarrhythmic medication." | 1.42 | Efficacy and safety of high-dose propranolol for the management of infant supraventricular tachyarrhythmias. ( Barton, AL; Kim, JJ; Miyake, C; Moffett, BS; Valdes, SO, 2015) |
| "Infantile hemangiomas are the most common vascular tumors in childhood." | 1.42 | Delayed-onset of multiple cutaneous infantile hemangiomas due to propranolol: a case report. ( del Boz González, J; Navarro Morón, J; Porcel Chacón, R, 2015) |
| "Cirrhosis recurrence is frequent after orthotopic liver transplantation for hepatitis C virus (HCV)." | 1.39 | Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control study. ( Abraldes, JG; Berzigotti, A; Bosch, J; Carrión, JA; Forns, X; García-Pagán, JC; García-Valdecasas, JC; Navasa, M; Schepis, F; Vukotic, R, 2013) |
| "Adenosine has been well studied as a mainstay treatment, but the methods of adenosine administration have not been very well delineated." | 1.38 | Intraosseous infusion is unreliable for adenosine delivery in the treatment of supraventricular tachycardia. ( Goodman, IS; Lu, CJ, 2012) |
| "Laughter-induced syncope is thought to be a subtype of the vagal mediated syncopal attacks." | 1.38 | [Recurrent gelastic syncopes]. ( El Otmani, H; Fadel, H; Moutaouakil, F; Slassi, I, 2012) |
| "Childhood headache is a common condition." | 1.36 | [Update on current care guidelines; childhood headache]. ( , 2010) |
| "Recurrent life-threatening episodes of ventricular tachycardia persisted despite maximal antiarrhythmic theraphy with amiodarone, metoprolol and mexiletine." | 1.33 | Suppression by propranolol and amiodarone of an electrical storm refractory to metoprolol and amiodarone. ( Anastasiou-Nana, MI; Kanakakis, J; Rokas, S; Tsagalou, EP, 2005) |
| "Cyclic-vomiting syndrome is probably a common but often not recognised syndrome." | 1.33 | [Cyclic vomiting in children]. ( Fontijn, JR; Rövekamp, MH; van der Woerd, WL; van Diemen-Steenvoorde, JA, 2006) |
| "The variceal recurrence rate was 65 and 38." | 1.32 | Long-term outcome after sclerotherapy with or without a beta-blocker for variceal bleeding in children. ( Elkabes, B; Saner, G; Sökücü, S; Süoglu, OD, 2003) |
| "Recurrence was defined as documented SVT at >1 year of age." | 1.32 | Frequency of recurrence among infants with supraventricular tachycardia and comparison of recurrence rates among those with and without preexcitation and among those with and without response to digoxin and/or propranolol therapy. ( Fenrich, AL; Friedman, RA; Kertesz, NJ; Smith, EO; Snyder, CS; Tortoriello, TA, 2003) |
| "Following a 6th accident, severe PTSD symptoms reemerged." | 1.31 | Propranolol for reemergent posttraumatic stress disorder following an event of retraumatization: a case study. ( Cahill, L; Taylor, F, 2002) |
| "The first patient had recurrence of thyrotoxicosis and paralysis after 16 months, whereas the second patient has remained symptom-free." | 1.31 | [Thyrotoxic periodic paralysis--an unusual complication of hyperthyroidism]. ( Aanderud, S; Bindoff, L; Bleskestad, IH; Holm, PI; Lien, EA; Mellgren, G, 2002) |
| "Prednisone was added after another episode of paralysis." | 1.30 | Normokalemic thyrotoxic periodic paralysis: a new therapeutic strategy. ( González-Treviño, O; Rosas-Guzmán, J, 1999) |
| "Verapamil was used in one infant with AV node reentry tachycardia." | 1.29 | Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants. ( Saul, JP; Walsh, EP; Weindling, SN, 1996) |
| "In these patients intrinsic sinus node disease can be assumed." | 1.27 | [Functional autonomic blockade in the diagnosis of functional sinus node disorders]. ( Kasper, W; Meinertz, T; Meyer, J; Pop, T; Steppert, C; Treese, N, 1984) |
| "Forty-five patients survived a cardiac arrest due to ventricular tachycardia (VT) or ventricular fibrillation (VF)." | 1.27 | Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest. ( Hess, DS; Morady, F; Scheinman, MM; Shapiro, W; Shen, E; Sung, RJ, 1983) |
| "Sclerotherapy of esophageal varices consists in obstruction of the varicosities." | 1.27 | [Prevention of recurrent hemorrhage due to portal hypertension]. ( Lebrec, D, 1986) |
| "100) rebled from esophageal varices within a mean time of 8." | 1.27 | [Propranolol prevention of hemorrhagic recurrence caused by rupture of esophageal varices: worsened prognosis in ascites and jaundice]. ( Attali, P; Buffet, C; Etienne, JP; Ink, O; Pelletier, G; Servent, L, 1985) |
| "Thyrotoxic periodic paralysis has now been well characterized in the literature: it occurs primarily in Orientals with an overwhelming male preponderance and a higher association of specific HLA antigens." | 1.27 | Thyrotoxic periodic paralysis. ( Arguelles, DJ; Ferreiro, JE; Rams, H, 1986) |
| "Bleeding from ileal varices can be managed by either local control or portal vein decompression." | 1.27 | Variceal bleeding from an ileostomy stoma. ( Dunn, GD; McGrew, W; Wang, MM, 1985) |
| "Propranolol was administered to 5 patients, in doses of 60-80 mg daily." | 1.26 | Injection sclerotherapy of esophageal varices. ( Jorge, AD, 1982) |
| "Thus nifedipine appears to be an efficacious agent in the treatment of refractory rest angina in patients with obstructive coronary artery disease." | 1.26 | Efficacy of nifedipine in rest angina refractory to propranolol and nitrates in patients with obstructive coronary artery disease. ( Banka, VS; Bodenheimer, MM; Feldman, M; Helfant, RH; Moses, JW; Wertheimer, JH, 1981) |
| "The place of pacemakers in the treatment of tachyarrhythmias has expanded far beyond the initial role in the brady-tachy syndrome, of providing a "minimum guaranteed rate" while medications suppress the tachycardia." | 1.26 | Cardiac pacing and pacemakers II. Serial electrophysiologic-pharmacologic testing for control of recurrent tachyarrhythmias. ( Altschuler, H; Cohen, HL; Escher, DJ; Fisher, JD; Furman, S; Mehra, R, 1977) |
| "Two adults with Bartter's syndrome were treated first with propranolol and a potassium-sparing diuretic and then with indomethacin for 22 months." | 1.26 | [Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis]. ( Dray, F; Favre, L; Flory, ED; Glasson, P; Vallotton, MB, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 120 (44.61) | 18.7374 |
| 1990's | 73 (27.14) | 18.2507 |
| 2000's | 35 (13.01) | 29.6817 |
| 2010's | 36 (13.38) | 24.3611 |
| 2020's | 5 (1.86) | 2.80 |
| Authors | Studies |
|---|---|
| Allam, MM | 1 |
| El-Zawawy, HT | 1 |
| Kader Okda, AA | 1 |
| Ali Alshaikh, A | 1 |
| Ghazy, RM | 1 |
| Dany, M | 1 |
| Shao, R | 1 |
| Li, Z | 1 |
| Wang, J | 2 |
| Qi, R | 1 |
| Liu, Q | 1 |
| Zhang, W | 1 |
| Mao, X | 1 |
| Song, X | 1 |
| Li, L | 1 |
| Liu, Y | 1 |
| Zhao, X | 1 |
| Liu, C | 1 |
| Li, X | 4 |
| Zuo, C | 1 |
| Wang, W | 1 |
| Qi, X | 2 |
| Nicastro, ES | 1 |
| Majdalani, MG | 1 |
| Abello, MS | 1 |
| Doiny, DG | 1 |
| Falconi, EC | 1 |
| Díaz, CJ | 1 |
| Moltedo, JM | 1 |
| El-Taweel, AEI | 1 |
| Al-Refaie, AAA | 1 |
| Salem, KHA | 1 |
| Salem, RM | 1 |
| Chen, Y | 1 |
| Liu, X | 1 |
| Guo, SW | 1 |
| Bolin, EH | 1 |
| Lang, SM | 1 |
| Tang, X | 1 |
| Collins, RT | 1 |
| Lv, Y | 1 |
| He, C | 1 |
| Wang, Z | 2 |
| Yin, Z | 1 |
| Niu, J | 1 |
| Guo, W | 1 |
| Bai, W | 1 |
| Zhang, H | 3 |
| Xie, H | 1 |
| Yao, L | 1 |
| Li, T | 1 |
| Wang, Q | 1 |
| Chen, H | 2 |
| Liu, H | 1 |
| Wang, E | 1 |
| Xia, D | 1 |
| Luo, B | 1 |
| Yuan, J | 1 |
| Han, N | 1 |
| Zhu, Y | 1 |
| Xia, J | 1 |
| Cai, H | 1 |
| Yang, Z | 1 |
| Wu, K | 1 |
| Fan, D | 1 |
| Han, G | 1 |
| Chang, L | 1 |
| Lv, D | 1 |
| Yu, Z | 1 |
| Ma, G | 1 |
| Ying, H | 1 |
| Qiu, Y | 1 |
| Gu, Y | 1 |
| Jin, Y | 1 |
| Lin, X | 1 |
| Pépin, V | 1 |
| Gagné, N | 1 |
| Rottembourg, D | 1 |
| Chesworth, R | 1 |
| Corbit, LH | 1 |
| Ramdhani, D | 1 |
| Seedat, RY | 1 |
| Li, LN | 1 |
| Sun, XY | 1 |
| Wang, GC | 1 |
| Tian, XG | 1 |
| Zhang, MY | 1 |
| Jiang, KT | 1 |
| Zhang, CQ | 1 |
| Schepis, F | 1 |
| Vukotic, R | 1 |
| Berzigotti, A | 1 |
| Carrión, JA | 1 |
| Forns, X | 1 |
| Abraldes, JG | 2 |
| García-Valdecasas, JC | 1 |
| Navasa, M | 1 |
| García-Pagán, JC | 3 |
| Bosch, J | 6 |
| Bjelakovic, B | 1 |
| Bojanovic, M | 1 |
| Lukic, S | 1 |
| Saranac, L | 1 |
| Vukomanovic, V | 1 |
| Prijic, S | 1 |
| Zivkovic, N | 1 |
| Randjelovic, D | 1 |
| Ollague Sierra, JE | 1 |
| Ollague Torres, JM | 1 |
| Chu, DH | 1 |
| Castelo-Soccio, L | 1 |
| Wan, J | 1 |
| Gelfand, JM | 1 |
| Shaddy, RE | 1 |
| Shah, KN | 1 |
| Perman, MJ | 1 |
| Treat, JR | 1 |
| Yan, AC | 1 |
| Liao, WC | 1 |
| Chen, PH | 1 |
| Hou, MC | 1 |
| Chang, CJ | 1 |
| Su, CW | 1 |
| Lin, HC | 1 |
| Lee, FY | 1 |
| Barton, AL | 1 |
| Moffett, BS | 1 |
| Valdes, SO | 1 |
| Miyake, C | 1 |
| Kim, JJ | 1 |
| Bonilha, DQ | 1 |
| Lenz, L | 1 |
| Correia, LM | 1 |
| Rodrigues, RA | 1 |
| de Paulo, GA | 1 |
| Ferrari, AP | 1 |
| Della Libera, E | 1 |
| Hernández-Martínez, P | 1 |
| Gallego-Pinazo, R | 1 |
| Dolz-Marco, R | 1 |
| Arevalo, JF | 1 |
| Díaz-Llopis, M | 1 |
| Cisneros Lanuza, A | 1 |
| Luo, X | 1 |
| Tsauo, J | 1 |
| Zhou, B | 1 |
| Porcel Chacón, R | 1 |
| del Boz González, J | 1 |
| Navarro Morón, J | 1 |
| Sauerbruch, T | 1 |
| Mengel, M | 1 |
| Dollinger, M | 1 |
| Zipprich, A | 1 |
| Rössle, M | 2 |
| Panther, E | 1 |
| Wiest, R | 1 |
| Caca, K | 1 |
| Hoffmeister, A | 1 |
| Lutz, H | 1 |
| Schoo, R | 1 |
| Lorenzen, H | 1 |
| Trebicka, J | 1 |
| Appenrodt, B | 1 |
| Schepke, M | 1 |
| Fimmers, R | 1 |
| Xue, YX | 1 |
| Deng, JH | 1 |
| Chen, YY | 1 |
| Zhang, LB | 1 |
| Wu, P | 1 |
| Huang, GD | 1 |
| Luo, YX | 1 |
| Bao, YP | 1 |
| Wang, YM | 1 |
| Shaham, Y | 1 |
| Shi, J | 1 |
| Lu, L | 1 |
| Lebrec, L | 1 |
| Barski, L | 1 |
| Nevzorov, R | 1 |
| Lotkowitz, A | 1 |
| Shleyfer, E | 1 |
| Liel, Y | 1 |
| Sarin, SK | 3 |
| Gupta, N | 1 |
| Jha, SK | 1 |
| Agrawal, A | 1 |
| Mishra, SR | 2 |
| Sharma, BC | 1 |
| Kumar, A | 2 |
| Chander Sharma, B | 1 |
| Leboulanger, N | 1 |
| Fayoux, P | 1 |
| Teissier, N | 1 |
| Cox, A | 1 |
| Van Den Abbeele, T | 1 |
| Carrabin, L | 1 |
| Couloigner, V | 1 |
| Nicollas, R | 1 |
| Triglia, JM | 1 |
| Ayari, S | 1 |
| Froehlich, P | 1 |
| Lescanne, E | 1 |
| Marianowski, R | 1 |
| Mom, T | 1 |
| Mondain, M | 1 |
| Marie, JP | 1 |
| Roger, G | 1 |
| Garabédian, EN | 1 |
| Denoyelle, F | 1 |
| Maturo, S | 1 |
| Tse, SM | 1 |
| Kinane, TB | 1 |
| Hartnick, CJ | 1 |
| Ganz, PA | 1 |
| Cole, SW | 1 |
| Price, CJ | 1 |
| Lattouf, C | 1 |
| Baum, B | 1 |
| McLeod, M | 1 |
| Schachner, LA | 1 |
| Duarte, AM | 1 |
| Connelly, EA | 1 |
| Menezes, MD | 1 |
| McCarter, R | 1 |
| Greene, EA | 1 |
| Bauman, NM | 1 |
| Goodman, IS | 1 |
| Lu, CJ | 1 |
| Wu, Y | 1 |
| Li, Y | 1 |
| Yang, X | 1 |
| Sui, N | 1 |
| El Otmani, H | 1 |
| Moutaouakil, F | 1 |
| Fadel, H | 1 |
| Slassi, I | 1 |
| dos Santos, JM | 1 |
| Ferreira, AR | 1 |
| Fagundes, ED | 1 |
| Ferreira, AP | 1 |
| Ferreira, LS | 1 |
| Magalhães, MC | 1 |
| Bittencourt, PF | 1 |
| Carvalho, SD | 1 |
| Figueiredo Filho, PP | 1 |
| Penna, FJ | 1 |
| Georgountzou, A | 1 |
| Karavitakis, E | 1 |
| Klimentopoulou, A | 1 |
| Xaidara, A | 1 |
| Kakourou, T | 1 |
| Latorre Martinez, N | 1 |
| Betlloch Mas, I | 1 |
| Monteagudo Paz, AF | 1 |
| Lucas Boronat, J | 1 |
| Sanatani, S | 1 |
| Potts, JE | 1 |
| Reed, JH | 1 |
| Saul, JP | 2 |
| Stephenson, EA | 1 |
| Gibbs, KA | 1 |
| Anderson, CC | 1 |
| Mackie, AS | 1 |
| Ro, PS | 1 |
| Tisma-Dupanovic, S | 1 |
| Kanter, RJ | 1 |
| Batra, AS | 1 |
| Fournier, A | 1 |
| Blaufox, AD | 1 |
| Singh, HR | 1 |
| Ross, BA | 1 |
| Wong, KK | 1 |
| Bar-Cohen, Y | 1 |
| McCrindle, BW | 1 |
| Etheridge, SP | 1 |
| Tsiskarishvili, NV | 1 |
| Katsitadze, A | 1 |
| Tsiskarishvili, Ts | 1 |
| Flevari, P | 2 |
| Livanis, EG | 2 |
| Theodorakis, GN | 2 |
| Zarvalis, E | 1 |
| Mesiskli, T | 1 |
| Kremastinos, DT | 2 |
| Erami, C | 1 |
| Ho, JG | 1 |
| French, DM | 1 |
| Faber, JE | 1 |
| Taylor, F | 1 |
| Cahill, L | 1 |
| Tarantino, I | 1 |
| Turnes, J | 1 |
| Rodés, J | 3 |
| Alegria, JR | 1 |
| Gersh, BJ | 1 |
| Scott, CG | 1 |
| Hodge, DO | 1 |
| Hammill, SC | 1 |
| Shen, WK | 1 |
| Sökücü, S | 1 |
| Süoglu, OD | 1 |
| Elkabes, B | 1 |
| Saner, G | 1 |
| Evrard, S | 1 |
| Dumonceau, JM | 1 |
| Delhaye, M | 1 |
| Golstein, P | 1 |
| Devière, J | 1 |
| Le Moine, O | 1 |
| Nidegger, D | 1 |
| Ragot, S | 1 |
| Berthelémy, P | 1 |
| Masliah, C | 2 |
| Pilette, C | 1 |
| Martin, T | 3 |
| Bianchi, A | 1 |
| Paupard, T | 1 |
| Silvain, C | 1 |
| Beauchant, M | 1 |
| Kyrle, PA | 1 |
| Eichinger, S | 1 |
| Tortoriello, TA | 1 |
| Snyder, CS | 1 |
| Smith, EO | 1 |
| Fenrich, AL | 1 |
| Friedman, RA | 1 |
| Kertesz, NJ | 1 |
| Krikis, N | 1 |
| Tziomalos, K | 1 |
| Perifanis, V | 1 |
| Vakalopoulou, S | 1 |
| Karagiannis, A | 1 |
| Garipidou, V | 1 |
| Harsoulis, F | 1 |
| Tsagalou, EP | 1 |
| Kanakakis, J | 1 |
| Rokas, S | 1 |
| Anastasiou-Nana, MI | 1 |
| Akar, S | 1 |
| Comlekci, A | 1 |
| Birlik, M | 1 |
| Onen, F | 1 |
| Sari, I | 1 |
| Gurler, O | 1 |
| Bekis, R | 1 |
| Akkoc, N | 1 |
| Chalasani, N | 1 |
| Boyer, TD | 2 |
| Nakamura, T | 1 |
| Sugawara, Y | 1 |
| Ishida, T | 1 |
| Ikeda, N | 1 |
| Funayama, H | 1 |
| Yasu, T | 1 |
| Kubo, N | 1 |
| Fujii, M | 1 |
| Kawakami, M | 1 |
| Takanashi, S | 1 |
| Saito, M | 1 |
| Jutabha, R | 1 |
| Jensen, DM | 1 |
| Martin, P | 1 |
| Savides, T | 1 |
| Han, SH | 1 |
| Gornbein, J | 1 |
| Gierelak, G | 1 |
| Makowski, K | 1 |
| Guzik, P | 1 |
| Kramarz, E | 1 |
| Kowal, J | 1 |
| Cholewa, M | 1 |
| Dowidar, N | 1 |
| Hafez, A | 1 |
| Abdel Baki, M | 1 |
| De Madaria, E | 1 |
| Palazón, JM | 1 |
| Pérez-Mateo, M | 1 |
| van der Woerd, WL | 1 |
| Fontijn, JR | 1 |
| Rövekamp, MH | 1 |
| van Diemen-Steenvoorde, JA | 1 |
| Leftheriotis, D | 1 |
| Karabela, G | 1 |
| Aggelopoulou, N | 1 |
| Eldadah, BA | 1 |
| Pechnik, SL | 1 |
| Holmes, CS | 1 |
| Moak, JP | 1 |
| Saleem, AM | 1 |
| Goldstein, DS | 1 |
| Tatham, A | 1 |
| Macfarlane, A | 1 |
| Jayakrishnan, MP | 1 |
| Krishnakumar, P | 1 |
| Norberto, L | 1 |
| Polese, L | 1 |
| Cillo, U | 1 |
| Grigoletto, F | 1 |
| Burroughs, AK | 4 |
| Neri, D | 1 |
| Zanus, G | 1 |
| Boccagni, P | 1 |
| Burra, P | 1 |
| D'Amico, DF | 1 |
| Amaki, M | 1 |
| Kamide, K | 1 |
| Takiuchi, S | 1 |
| Niizuma, S | 1 |
| Horio, T | 1 |
| Kawano, Y | 1 |
| Schröder, R | 1 |
| Lebrec, D | 8 |
| Nouel, O | 2 |
| Bernuau, J | 2 |
| Bouygues, M | 1 |
| Rueff, B | 2 |
| Benhamou, JP | 3 |
| Moser, M | 1 |
| Gorlin, R | 1 |
| Furberg, C | 1 |
| Staessen, J | 1 |
| Bulpitt, C | 1 |
| Cattaert, A | 1 |
| Fagard, R | 1 |
| Vanhees, L | 1 |
| Amery, A | 1 |
| Chang, MS | 1 |
| Sung, RJ | 3 |
| Tai, TY | 1 |
| Lin, SL | 1 |
| Liu, PH | 1 |
| Chiang, BN | 1 |
| Vacheron, A | 1 |
| Baubion, N | 1 |
| Delage, F | 1 |
| Goldstein, S | 8 |
| Rotmensch, HH | 1 |
| Vlasses, PH | 1 |
| Ferguson, RK | 1 |
| Ostapiuk, FE | 1 |
| Khvoĭnitskiĭ, VA | 1 |
| DeMets, DL | 1 |
| Hardy, R | 1 |
| Friedman, LM | 4 |
| Lan, KK | 1 |
| Byington, RP | 1 |
| Cobb, LA | 1 |
| Hallstrom, AP | 1 |
| Weaver, WD | 1 |
| Trobaugh, GB | 1 |
| Greene, HL | 2 |
| Gillis, AM | 1 |
| Clusin, WT | 1 |
| Poynard, T | 6 |
| Naveau, S | 2 |
| Poitrine, A | 1 |
| Lebourgeois, P | 1 |
| Hilpert, G | 1 |
| Chaput, JC | 2 |
| Khan, AH | 1 |
| Jenkins, WJ | 1 |
| Sherlock, S | 1 |
| Dunk, A | 1 |
| Walt, RP | 1 |
| Osuafor, TO | 1 |
| Mackie, S | 1 |
| Dick, R | 1 |
| Reynolds, TB | 1 |
| Korman, MG | 1 |
| Gascon, GG | 1 |
| Larrey, D | 1 |
| Bercoff, E | 2 |
| Pessayre, D | 1 |
| Treese, N | 1 |
| Steppert, C | 1 |
| Kasper, W | 1 |
| Meinertz, T | 1 |
| Pop, T | 1 |
| Meyer, J | 1 |
| Golikov, AP | 1 |
| Polumiskov, VIu | 1 |
| Berestov, AA | 1 |
| Riabinin, VA | 1 |
| Halawa, B | 1 |
| Morady, F | 1 |
| Scheinman, MM | 1 |
| Hess, DS | 1 |
| Shen, E | 1 |
| Shapiro, W | 1 |
| Chevrel, B | 1 |
| Jorge, AD | 1 |
| Maringhini, A | 1 |
| Simonetti, RM | 1 |
| Marcenò, MP | 1 |
| Pagliaro, L | 1 |
| Baber, NS | 1 |
| Evans, DW | 1 |
| Howitt, G | 1 |
| Thomas, M | 1 |
| Wilson, T | 1 |
| Lewis, JA | 2 |
| Dawes, PM | 1 |
| Handler, K | 1 |
| Tuson, R | 1 |
| Hillon, P | 1 |
| Jones, RJ | 1 |
| Hansteen, V | 1 |
| Furuse, A | 1 |
| Matsuo, H | 1 |
| Nakanishi, S | 1 |
| Yamaguchi, H | 1 |
| Harumi, K | 1 |
| Cheanvechai, C | 1 |
| Matsunaga, H | 1 |
| Saigusa, M | 1 |
| Moses, JW | 1 |
| Wertheimer, JH | 1 |
| Bodenheimer, MM | 1 |
| Banka, VS | 1 |
| Feldman, M | 1 |
| Helfant, RH | 1 |
| Herling, IM | 1 |
| Horowitz, LN | 1 |
| Josephson, ME | 1 |
| Shevitz, SA | 1 |
| Jameison, RC | 1 |
| Petrie, WM | 1 |
| Crook, JE | 1 |
| Gay, JL | 1 |
| Nash, ML | 1 |
| Cairns, JA | 1 |
| Klassen, GA | 1 |
| Feu, F | 2 |
| Luca, A | 1 |
| Terés, J | 2 |
| Escorsell, A | 1 |
| Osterziel, KJ | 1 |
| Abraham, AS | 1 |
| Balkin, J | 1 |
| Rosenmann, D | 1 |
| Ilan, M | 1 |
| Klutstein, M | 1 |
| Zion, MM | 1 |
| Blanc, P | 1 |
| Roy-Byrne, PP | 1 |
| Sullivan, MD | 1 |
| Cowley, DS | 1 |
| Ries, RK | 1 |
| Vickers, C | 1 |
| Rhodes, J | 1 |
| Chesner, I | 1 |
| Hillenbrand, P | 1 |
| Dawson, J | 1 |
| Cockel, R | 1 |
| Adams, D | 1 |
| O'Connor, H | 1 |
| Dykes, P | 1 |
| Bradby, H | 1 |
| Brechignac, X | 1 |
| Broussolle, C | 1 |
| Nove-Josserand, R | 1 |
| Vital-Durand, D | 1 |
| Orgiazzi, J | 1 |
| Levrat, R | 1 |
| Tsimmerman, IaS | 1 |
| Budnik, IuB | 1 |
| Syman, LN | 1 |
| Bergsmark, J | 1 |
| Gadeholt, G | 1 |
| Kitano, S | 1 |
| Walker, M | 1 |
| Trajano, LR | 1 |
| Alberti, KG | 1 |
| Kendall-Taylor, P | 1 |
| Valsecchi, R | 1 |
| Leighissa, P | 1 |
| Piazzolla, S | 1 |
| Naldi, L | 1 |
| Cainelli, T | 1 |
| Bordas, JM | 1 |
| Garcia Pagán, JC | 1 |
| Cirera, I | 1 |
| Gil, R | 1 |
| Kaźmierczak, J | 1 |
| Kornacewicz-Jach, Z | 1 |
| Kisły, M | 1 |
| Przybycień, K | 1 |
| Avgerinos, A | 1 |
| Rekoumis, G | 1 |
| Klonis, C | 1 |
| Papadimitriou, N | 1 |
| Gouma, P | 1 |
| Pournaras, S | 1 |
| Raptis, S | 1 |
| Acharya, SK | 1 |
| Dasarathy, S | 1 |
| Saksena, S | 1 |
| Pande, JN | 1 |
| Jirón, MI | 1 |
| Soto, JR | 1 |
| Wolff, C | 1 |
| Armas, R | 1 |
| Constantinescu, CS | 1 |
| Chang, AP | 1 |
| McCluskey, LF | 1 |
| Gheorghiade, M | 3 |
| Shivkumar, K | 1 |
| Schultz, L | 3 |
| Jafri, S | 1 |
| Tilley, B | 3 |
| Weindling, SN | 1 |
| Walsh, EP | 1 |
| Kaufman, HE | 1 |
| Varnell, ED | 1 |
| Gebhardt, BM | 1 |
| Thompson, HW | 1 |
| Hill, JM | 1 |
| Elsayed, SS | 1 |
| Shiha, G | 1 |
| Hamid, M | 1 |
| Farag, FM | 1 |
| Azzam, F | 1 |
| Awad, M | 1 |
| Forbes, D | 1 |
| Withers, G | 1 |
| Groszmann, RJ | 1 |
| Urbistondo, M | 1 |
| Torres, EA | 1 |
| Castro, F | 1 |
| Oharriz, J | 1 |
| Medina, R | 1 |
| Molina, A | 1 |
| Marquez, E | 1 |
| Rubio, CE | 1 |
| Lemler, MS | 1 |
| Schaffer, MS | 1 |
| Bernard, B | 1 |
| Mathurin, P | 1 |
| Opolon, P | 1 |
| Deibert, P | 1 |
| Haag, K | 1 |
| Ochs, A | 1 |
| Olschewski, M | 1 |
| Siegerstetter, V | 1 |
| Hauenstein, KH | 1 |
| Geiger, R | 1 |
| Stiepak, C | 1 |
| Keller, W | 1 |
| Blum, HE | 1 |
| Sauer, P | 1 |
| Theilmann, L | 1 |
| Stremmel, W | 1 |
| Benz, C | 1 |
| Richter, GM | 1 |
| Stiehl, A | 1 |
| Jalan, R | 1 |
| Finlayson, ND | 1 |
| Hayes, PC | 3 |
| Alvarez, F | 1 |
| McCormick, PA | 2 |
| Patch, D | 1 |
| Greenslade, L | 1 |
| Chin, J | 1 |
| McIntyre, N | 1 |
| Di Girolamo, E | 1 |
| Di Iorio, C | 1 |
| Sabatini, P | 1 |
| Leonzio, L | 1 |
| Barsotti, A | 1 |
| Worawattanakul, M | 1 |
| Rhoads, JM | 1 |
| Lichtman, SN | 1 |
| Ulshen, MH | 1 |
| González-Treviño, O | 1 |
| Rosas-Guzmán, J | 1 |
| Lamba, GS | 1 |
| Kumar, M | 1 |
| Misra, A | 1 |
| Murthy, NS | 1 |
| van Poeck, KJ | 1 |
| Deleu, D | 1 |
| Hanssens, Y | 1 |
| Chen, D | 1 |
| Zou, J | 1 |
| Deschênes, M | 1 |
| Barkun, AN | 1 |
| Nademanee, K | 1 |
| Taylor, R | 1 |
| Bailey, WE | 1 |
| Rieders, DE | 1 |
| Kosar, EM | 1 |
| Duhamel, C | 1 |
| Mauillon, J | 1 |
| Berkelmans, I | 1 |
| Bourienne, A | 1 |
| Tranvouez, JL | 2 |
| Lo, GH | 1 |
| Lai, KH | 1 |
| Cheng, JS | 1 |
| Hsu, PI | 1 |
| Chen, TA | 1 |
| Wang, EM | 1 |
| Lin, CK | 1 |
| Chiang, HT | 1 |
| Mellgren, G | 1 |
| Holm, PI | 1 |
| Lien, EA | 1 |
| Bleskestad, IH | 1 |
| Aanderud, S | 1 |
| Bindoff, L | 1 |
| Ross, J | 1 |
| Brechenmacher, JC | 1 |
| Fisher, JD | 1 |
| Cohen, HL | 1 |
| Mehra, R | 1 |
| Altschuler, H | 1 |
| Escher, DJ | 1 |
| Furman, S | 1 |
| Lown, B | 1 |
| Temte, JV | 1 |
| Reich, P | 1 |
| Gaughan, C | 1 |
| Regestein, Q | 1 |
| Hal, H | 1 |
| Huret, JF | 1 |
| Agier, B | 1 |
| Rosier, SP | 1 |
| Gueret, P | 1 |
| Kahn, JC | 1 |
| Farhat, MB | 1 |
| Bardet, J | 1 |
| Bourdarias, JP | 1 |
| Waters, DD | 1 |
| Theroux, P | 1 |
| Halphen, C | 1 |
| Mizgala, HF | 1 |
| Bille, B | 1 |
| Ludvigsson, J | 1 |
| Sanner, G | 1 |
| Favre, L | 1 |
| Glasson, P | 1 |
| Flory, ED | 1 |
| Dray, F | 1 |
| Vallotton, MB | 1 |
| Robertson, RM | 1 |
| Breinig, JB | 1 |
| Robertson, D | 1 |
| Reddy, CP | 1 |
| Gettes, LS | 1 |
| Mikol, F | 1 |
| Bouchareine, A | 1 |
| Fraisse, F | 1 |
| Le Pennec, PY | 1 |
| Mikol, J | 1 |
| Weber, MA | 1 |
| Wei, JY | 1 |
| Bulkley, BH | 1 |
| Schaeffer, AH | 1 |
| Reid, PR | 1 |
| Mason, JW | 1 |
| Winkle, RA | 2 |
| Selden, R | 1 |
| Neill, WA | 1 |
| Ritzmann, LW | 1 |
| Okies, JE | 1 |
| Anderson, RP | 1 |
| Myers, MG | 1 |
| Wisenberg, G | 1 |
| Harner, RH | 1 |
| Boyd, RB | 1 |
| Alderman, EL | 1 |
| Fitzgerald, JW | 1 |
| Harrison, DC | 1 |
| Kahn, A | 1 |
| Morris, JJ | 1 |
| Citron, P | 1 |
| Doyle, TJ | 1 |
| McGregor, WR | 1 |
| Fox, PS | 1 |
| Maddison, FE | 1 |
| Rodgers, RE | 1 |
| Kauffman, HM | 1 |
| Downar, E | 1 |
| Waxman, MB | 1 |
| Hernandez, A | 1 |
| Strauss, A | 1 |
| Kleiger, RE | 1 |
| Goldring, D | 1 |
| Voisard, R | 1 |
| Seitzer, U | 1 |
| Dartsch, PC | 1 |
| Roth, D | 1 |
| Osterhues, H | 1 |
| Kochs, M | 1 |
| Hombach, V | 1 |
| Muñoz, SJ | 1 |
| Hamid, S | 1 |
| Jafri, W | 1 |
| Garden, OJ | 2 |
| Carter, DC | 2 |
| Ink, O | 3 |
| Reville, M | 1 |
| Anciaux, ML | 1 |
| Lenoir, C | 1 |
| Marill, JL | 1 |
| Labadie, H | 1 |
| Perrin, D | 2 |
| Dwivedi, M | 1 |
| Bhargava, DK | 1 |
| Ramachandran, K | 1 |
| Vinel, JP | 1 |
| Lamouliatte, H | 1 |
| Cales, P | 2 |
| Combis, JM | 1 |
| Roux, D | 1 |
| Desmorat, H | 1 |
| Pradere, B | 1 |
| Barjonet, G | 1 |
| Quinton, A | 1 |
| Barjonnet, G | 1 |
| Schwartz, J | 1 |
| Rozenfeld, V | 1 |
| Habot, B | 1 |
| Wruck, U | 1 |
| Wermke, W | 1 |
| Scott, JS | 1 |
| Berney, CE | 1 |
| Derksen, FJ | 1 |
| Robinson, NE | 1 |
| Perry, JC | 1 |
| Garson, A | 1 |
| Marshall, JB | 1 |
| Pérez-Ayuso, RM | 1 |
| Piqué, JM | 1 |
| Panés, J | 1 |
| González, A | 1 |
| Pérez, R | 1 |
| Rigau, J | 1 |
| Quintero, E | 1 |
| Valderrama, R | 1 |
| Viver, J | 1 |
| Taupignon, A | 1 |
| Lavignolle, A | 1 |
| Le Bodic, L | 1 |
| Holroyd, KA | 2 |
| Penzien, DB | 2 |
| Cordingley, GE | 1 |
| Kanazawa, H | 1 |
| Watari, A | 1 |
| Matsusaka, S | 1 |
| Tada, N | 1 |
| Miyata, K | 1 |
| Saitoh, H | 1 |
| Yoshizawa, M | 1 |
| Kuroda, H | 1 |
| Kobayashi, M | 1 |
| Booth, DC | 1 |
| Deupree, RH | 1 |
| Hultgren, HN | 1 |
| DeMaria, AN | 1 |
| Scott, SM | 1 |
| Luchi, RJ | 1 |
| Kidess, AI | 1 |
| Caplan, RH | 1 |
| Reynertson, RH | 1 |
| Wickus, G | 1 |
| Rossi, V | 1 |
| Burtin, P | 1 |
| Charneau, J | 1 |
| Person, B | 1 |
| Pujol, P | 1 |
| Valentin, S | 1 |
| D'Aubigny, N | 1 |
| Joubaud, F | 1 |
| Boyer, J | 1 |
| Kao, W | 2 |
| Davis, JM | 1 |
| Bouchier, IA | 1 |
| Westaby, D | 1 |
| Polson, RJ | 1 |
| Gimson, AE | 1 |
| Hayllar, K | 1 |
| Williams, R | 1 |
| Avezzano, ES | 1 |
| Seefe, LB | 1 |
| Lundell, L | 1 |
| Leth, R | 1 |
| Lind, T | 1 |
| Lönroth, H | 1 |
| Sjövall, M | 1 |
| Olbe, L | 1 |
| Qureshi, H | 1 |
| Zuberi, SJ | 1 |
| Alam, E | 1 |
| Kivity, S | 1 |
| Yarchovsky, J | 1 |
| Jensen, LS | 2 |
| Krarup, N | 2 |
| Conn, HO | 2 |
| Il'iash, MG | 1 |
| Kravtsova, LA | 1 |
| Babov, KD | 1 |
| Shcherbak, IaIu | 1 |
| Mills, PR | 1 |
| Birnie, GG | 1 |
| Murray, GD | 1 |
| Jafri, SM | 1 |
| Tilley, BC | 1 |
| Peters, R | 1 |
| Schultz, LR | 1 |
| Cox, JL | 1 |
| Gotlieb, AI | 1 |
| Kiire, CF | 1 |
| Parelon, G | 1 |
| Guiry, P | 1 |
| Daures, JP | 1 |
| Bories, P | 1 |
| Feneyrou, B | 1 |
| Ampelas, M | 1 |
| Bauret, P | 1 |
| Aubin, JP | 1 |
| Prioton, JB | 1 |
| Michel, H | 1 |
| Colombo, M | 1 |
| de Franchis, R | 1 |
| Tommasini, M | 1 |
| Sangiovanni, A | 1 |
| Dioguardi, N | 1 |
| Capron, JP | 1 |
| Poupon, R | 1 |
| Bouvry, M | 1 |
| Peters, RW | 2 |
| Muller, JE | 1 |
| Byington, R | 2 |
| Posel, D | 1 |
| Noakes, T | 1 |
| Kantor, P | 1 |
| Lambert, M | 1 |
| Opie, LH | 1 |
| O'Connor, KW | 1 |
| Lehman, G | 1 |
| Yune, H | 1 |
| Brunelle, R | 1 |
| Christiansen, P | 1 |
| Hast, J | 1 |
| Compton, M | 1 |
| McHenry, R | 1 |
| Klatte, E | 1 |
| Cockerill, E | 1 |
| Dollet, JM | 2 |
| Champigneulle, B | 2 |
| Evangelista, M | 1 |
| Bigard, MA | 2 |
| Gaucher, P | 2 |
| Greenberger, PA | 1 |
| Patterson, R | 1 |
| Tapio, CM | 1 |
| Griggs, T | 1 |
| Adams, K | 1 |
| Narvarte, H | 1 |
| Sheps, D | 1 |
| Meyer-Lehnert, H | 1 |
| Kramer, HJ | 1 |
| Heck, I | 1 |
| Sorger, M | 1 |
| Düsing, R | 1 |
| Krück, F | 1 |
| White, HD | 1 |
| Norris, RM | 1 |
| Brown, MA | 1 |
| Takayama, M | 1 |
| Maslowski, A | 1 |
| Bass, NM | 1 |
| Ormiston, JA | 1 |
| Whitlock, T | 1 |
| Franco, D | 1 |
| Smadja, C | 1 |
| Buffet, C | 2 |
| Fritsch, J | 1 |
| Pelletier, G | 2 |
| Honein, K | 1 |
| Attali, P | 2 |
| Etienne, JP | 2 |
| Aubert, A | 1 |
| Lemman, M | 1 |
| Fushteĭ, IM | 1 |
| Torbin, ES | 1 |
| Tatarintseva, NP | 1 |
| Patris, A | 1 |
| Marbet, UA | 1 |
| Straumann, A | 1 |
| Gyr, KE | 1 |
| Beglinger, C | 1 |
| Schaub, N | 1 |
| Bögtlin, J | 1 |
| Loosli, J | 1 |
| Kiowski, W | 1 |
| Ritz, R | 1 |
| Stalder, GA | 1 |
| Nguyen, NX | 1 |
| Yang, PT | 1 |
| Huycke, EC | 1 |
| Keung, EC | 1 |
| Deedwania, P | 1 |
| Villeneuve, JP | 1 |
| Pomier-Layrargues, G | 1 |
| Duguay, L | 1 |
| Lapointe, R | 1 |
| Tanguay, S | 1 |
| Marleau, D | 1 |
| Willems, B | 1 |
| Huet, PM | 1 |
| Infante-Rivard, C | 1 |
| Lavoie, P | 1 |
| el-Hawy, A | 1 |
| el Nasr, MS | 1 |
| Hussein, T | 1 |
| el-Sayed, AA | 1 |
| Arensberg, D | 1 |
| Romhilt, DW | 1 |
| Barker, A | 1 |
| Laubach, C | 1 |
| Wilner, GW | 1 |
| Queuniet, AM | 1 |
| Czernichow, P | 1 |
| Lerebours, E | 1 |
| Ducrotte, P | 1 |
| Colin, R | 1 |
| Coates, JT | 1 |
| Mirick, MJ | 1 |
| Rubino, FJ | 1 |
| Madias, JE | 1 |
| Wilmer, CI | 1 |
| Stein, B | 1 |
| Morris, DC | 1 |
| Servent, L | 1 |
| Bell, RL | 1 |
| Curb, JD | 1 |
| McIntyre, KM | 1 |
| Payton-Ross, C | 1 |
| Ferreiro, JE | 1 |
| Arguelles, DJ | 1 |
| Rams, H | 1 |
| Buchanan, D | 1 |
| Gillette, PC | 1 |
| Zinner, A | 1 |
| Crawford, F | 1 |
| Wang, MM | 1 |
| McGrew, W | 1 |
| Dunn, GD | 1 |
| Nakajima, K | 1 |
| Hirosawa, K | 1 |
| Onoda, B | 1 |
| Hershman, JM | 1 |
| Steinger, H | 1 |
| Häusler, H | 1 |
| Shrivastava, S | 2 |
| Bhatia, ML | 2 |
| Ticzon, AR | 1 |
| Whalen, RW | 1 |
| Greig, WR | 1 |
| Chung, EK | 1 |
| Roy, SB | 1 |
| Friedman, AP | 1 |
| Lundberg, A | 1 |
| Videbaek, J | 1 |
| Andersen, ED | 1 |
| Jacobsen, JR | 1 |
| Sandoe, E | 1 |
| Wennevold, A | 1 |
| Goolsby, JP | 1 |
| Oliva, PB | 1 |
| Silver, W | 1 |
| DeGuzman, A | 1 |
| Castel, Y | 1 |
| Roche, J | 1 |
| Le Fur, JM | 1 |
| Fogelholm, R | 1 |
| Szekely, P | 1 |
| Sideris, DA | 1 |
| Batson, GA | 1 |
| Dhurandhar, RW | 1 |
| Teasdale, SJ | 1 |
| Mahon, WA | 1 |
| Baker, G | 1 |
| Pimstone, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| HVPG-guided Laparoscopic Versus Endoscopic Therapy for Variceal Rebleeding in Portal Hypertension: A Multicenter Randomized Controlled Trial (CHESS1803)[NCT03783065] | 40 participants (Anticipated) | Interventional | 2019-01-02 | Recruiting | |||
| Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic Treatment Combined With Propranolol for Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis: A Randomized Controlled Trial[NCT01326949] | 52 participants (Actual) | Interventional | 2011-05-31 | Completed | |||
| Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Variceal Bleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis (PVT): A Multicenter Randomized Trial[NCT06122753] | 120 participants (Anticipated) | Interventional | 2024-01-31 | Not yet recruiting | |||
| Comparison of Endoscopic Variceal Ligation (EVL) and Propranolol in Secondary Prophylaxis of Variceal Bleeding in Patients With Non Cirrhotic Portal Hypertension (NCPH): A Prospective Randomized Controlled Trial[NCT01000779] | Phase 3 | 100 participants (Anticipated) | Interventional | 2005-01-31 | Completed | ||
| Endoscopic Cyanoacrylate Injection Versus Beta-Blockers for Secondary Prophylaxis of Gastric Variceal Bleed[NCT00888784] | 64 participants (Actual) | Interventional | 2006-08-31 | Completed | |||
| Multicenter Study of Antiarrhythmic Medications for Treatment of Infants With Supraventricular Tachycardia[NCT00390546] | Phase 3 | 72 participants (Actual) | Interventional | 2006-10-31 | Completed | ||
| Reliving the Traumatic Event in Posttraumatic Stress Disorder: An Emotional Memory Reactivation Pathology? An fMRI Study[NCT01239173] | Phase 3 | 5 participants (Actual) | Interventional | 2010-09-30 | Terminated (stopped due to Study stopped by promoter for lack of inclusion) | ||
| Pilot Study to Evaluate the Correlation Between ¹³C Methacetin Breath Test (MBT) and HVPG Measurement as a Tool for Identifying Responders to Portal Hypertension Therapy[NCT01851252] | Phase 1 | 19 participants (Actual) | Interventional | 2013-10-31 | Completed | ||
| Double Blind, Randomised, Placebo-controlled Study of Propranolol in Infantile Capillary Hemangiomas[NCT00744185] | Phase 2/Phase 3 | 14 participants (Actual) | Interventional | 2008-10-31 | Terminated (stopped due to Study halted prematurely due to some difficulties in recruitment of patients) | ||
| Is Capsule Endoscopy Accurate and Cost-effective Enough to Screen Cirrhotic Patients for Varices & Other Lesions?[NCT01079416] | 65 participants (Actual) | Observational | 2006-06-30 | Completed | |||
| Short-Term Oral Mifepristone for Central Serous Chorioretinopathy. A Placebo-controlled Dose Ranging Study of Mifepristone in the Treatment of CSC (STOMP-CSC)[NCT02354170] | Phase 2 | 16 participants (Actual) | Interventional | 2015-01-31 | Completed | ||
| [NCT00000492] | Phase 3 | 0 participants | Interventional | 1977-09-30 | Completed | ||
| CHESS-SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease: an International Multicenter Study (CHESS2102)[NCT04975477] | 1,000 participants (Anticipated) | Observational | 2021-07-16 | Not yet recruiting | |||
| Prophylactic Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias (PREVENT VT)[NCT01013714] | Phase 3 | 40 participants (Anticipated) | Interventional | 2021-07-26 | Recruiting | ||
| A Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III Study of Intravenous Terlipressin in Patients With Hepatorenal Syndrome Type 1[NCT00089570] | Phase 3 | 112 participants (Actual) | Interventional | 2004-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
In relation to the study drugs (NCT00390546)
Timeframe: 12 months
| Intervention | participants (Number) |
|---|---|
| Digoxin | 0 |
| Propranolol | 0 |
(NCT00390546)
Timeframe: 6 months or until study endpoints were reached
| Intervention | percentage of participants (Number) |
|---|---|
| Digoxin | 12 |
| Propranolol | 18 |
Infants treated with propranolol or digoxin (NCT00390546)
Timeframe: up to 110 days of treatment
| Intervention | participants (Number) |
|---|---|
| Digoxin | 6 |
| Propranolol | 12 |
32 reviews available for propranolol and Recrudescence
| Article | Year |
|---|---|
Beta-Blockers for Pyogenic Granuloma: A Systematic Review of Case Reports, Case Series, and Clinical Trials
Topics: Administration, Cutaneous; Administration, Oral; Adrenergic beta-Antagonists; Betaxolol; Clinical Tr | 2019 |
Beta-blockers in the prevention of gastrointestinal bleeding.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Clinical Trials as Topic; Esophageal and Gastr | 1990 |
Status of propranolol for treatment of infantile hemangioma and description of a randomized clinical trial.
Topics: Age Factors; Child; Child, Preschool; Hemangioma; Humans; Prednisolone; Propranolol; Recurrence; Tre | 2011 |
The risk of recurrent venous thromboembolism: the Austrian Study on Recurrent Venous Thromboembolism.
Topics: Adolescent; Adrenergic beta-Antagonists; Anticoagulants; Cohort Studies; Factor IX; Factor VIII; Fac | 2003 |
[Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
Topics: Adrenergic beta-Antagonists; Alprenolol; Anti-Arrhythmia Agents; Aspirin; Dipyridamole; Female; Fibr | 1981 |
Considerations in the long-term management of survivors of cardiac arrest.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Coronary Artery Bypass; Coronary Disease; | 1984 |
The role of beta-adrenergic receptor antagonists in the prevention of sudden cardiac death.
Topics: Action Potentials; Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Calcium; Calcium Channel Block | 1984 |
Management of upper gastrointestinal haemorrhage.
Topics: Adult; Aged; Combined Modality Therapy; Embolization, Therapeutic; Esophageal and Gastric Varices; E | 1983 |
Chronic and recurrent headaches in children and adolescents.
Topics: Adolescent; Analgesics; Angiography; Anticonvulsants; Biofeedback, Psychology; Child; Chronic Diseas | 1984 |
[Complications associated with sudden withdrawal of various drugs used in the treatment of cardiovascular diseases].
Topics: Cardiovascular Diseases; Clonidine; Guanethidine; Humans; Nitroglycerin; Nitroprusside; Propranolol; | 1981 |
Adjunctive treatment of benzodiazepine discontinuation syndromes: a review.
Topics: Anti-Anxiety Agents; Benzodiazepines; Carbamazepine; Clonidine; Combined Modality Therapy; Humans; P | 1993 |
Prophylactic therapy in cyclic vomiting syndrome.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Humans; Male; Migraine Disorders; Periodicity; P | 1995 |
Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis.
Topics: Adult; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Male; Middle Aged; Propranolol; | 1997 |
Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
Topics: Acute Disease; Animals; Clinical Trials as Topic; Coronary Circulation; Coronary Vasospasm; Drug Des | 1999 |
The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination | 2000 |
Prevention of first variceal bleeding: new prospects.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Esophageal and Gastric Varices; Gastrointesti | 1992 |
Balloon tamponade and vasoactive drugs in the control of acute variceal haemorrhage.
Topics: Antihypertensive Agents; Balloon Occlusion; Catheterization; Esophageal and Gastric Varices; Gastroi | 1992 |
Bleeding esophagogastric varices. Ways to treat active episodes and prevent recurrence.
Topics: Balloon Occlusion; Catheterization; Clinical Protocols; Education, Medical, Continuing; Endoscopy, G | 1991 |
Propranolol in the management of recurrent migraine: a meta-analytic review.
Topics: Adult; Female; Humans; Male; Meta-Analysis as Topic; Migraine Disorders; Prognosis; Propranolol; Rec | 1991 |
Long-term pharmacologic therapy of portal hypertension.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Hemodynamics; Humans; Hypertension, Portal; M | 1990 |
Meta-analysis of value of propranolol in prevention of variceal haemorrhage.
Topics: Adrenergic beta-Antagonists; Chi-Square Distribution; Drug Evaluation; Esophageal and Gastric Varice | 1990 |
Pharmacological versus non-pharmacological prophylaxis of recurrent migraine headache: a meta-analytic review of clinical trials.
Topics: Analysis of Variance; Biofeedback, Psychology; Humans; Meta-Analysis as Topic; Migraine Disorders; O | 1990 |
Prevention of recurrent variceal hemorrhage: to block or not to block?
Topics: Atenolol; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Prop | 1990 |
Review of antiplatelet drug use in preventing restenosis following percutaneous transluminal coronary angioplasty.
Topics: Angioplasty, Balloon; Aspirin; Calcium Channel Blockers; Coronary Disease; Cyclooxygenase Inhibitors | 1988 |
[Beta blockaders and portal hypertension].
Topics: Adrenergic beta-Antagonists; Animals; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertensio | 1989 |
[Sclerotherapy of esophageal varices using ethanol in combination with propranolol: clinical study of 30 patients].
Topics: Aged; Drug Therapy, Combination; Esophageal and Gastric Varices; Ethanol; Female; Gastrointestinal H | 1988 |
Ideal treatment of portal hypertension in 1985.
Topics: Acute Disease; Clinical Trials as Topic; Double-Blind Method; Endoscopy; Esophageal and Gastric Vari | 1985 |
Current thoughts on management of hyperthyroidism.
Topics: Antithyroid Agents; Dose-Response Relationship, Drug; Female; Humans; Hyperthyroidism; Hypoparathyro | 1972 |
[Complications after thyroid gland surgery].
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antithyroid Agents; Humans; Iodine; Oxygen Inhalatio | 1973 |
Refractory supraventricular tachycardias.
Topics: Atrial Fibrillation; Atrial Flutter; Bradycardia; Digitalis Glycosides; Electric Countershock; Elect | 1973 |
Treatment of thyrotoxicosis--the current position. 3. Radioiodine therapy. Special considerations.
Topics: Adult; Age Factors; Carbimazole; Chlorpromazine; Female; Heart Diseases; Humans; Hyperthyroidism; Hy | 1973 |
Cardiac arrhythmias. Rationale of drug therapy.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atropine; Bradycardia; Bretylium Compounds; Cardiac Gl | 1973 |
97 trials available for propranolol and Recrudescence
| Article | Year |
|---|---|
Azathioprine as an adjuvant therapy in severe Graves' disease: a randomized controlled open-label clinical trial.
Topics: Antibodies; Antithyroid Agents; Azathioprine; Carbimazole; Graves Disease; Humans; Propranolol; Recu | 2023 |
Hepatic venous pressure gradient-guided laparoscopic splenectomy and pericardial devascularisation versus endoscopic therapy for secondary prophylaxis for variceal rebleeding in portal hypertension (CHESS1803): study protocol of a multicenter randomised c
Topics: China; Combined Modality Therapy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Human | 2020 |
Propranolol Versus Digoxin in the Neonate for Supraventricular Tachycardia (from the Pediatric Health Information System).
Topics: Anti-Arrhythmia Agents; Arkansas; Digoxin; Dose-Response Relationship, Drug; Female; Follow-Up Studi | 2017 |
Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial.
Topics: Adult; Combined Modality Therapy; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastroi | 2018 |
The therapeutic efficacy of propranolol in children with recurrent primary epistaxis.
Topics: Adrenergic beta-Antagonists; Child; Child, Preschool; Dose-Response Relationship, Drug; Epistaxis; F | 2013 |
Endoscopic ultrasonography assessment of para-esophageal varices predicts efficacy of propranolol in preventing recurrence of esophageal varices.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Endosonography; Esophageal and Gastric Var | 2015 |
Propranolol associated with endoscopic band ligation reduces recurrence of esophageal varices for primary prophylaxis of variceal bleeding: a randomized-controlled trial.
Topics: Adrenergic beta-Antagonists; Adult; Combined Modality Therapy; Endoscopy, Gastrointestinal; Esophage | 2015 |
Advanced Cirrhosis Combined with Portal Vein Thrombosis: A Randomized Trial of TIPS versus Endoscopic Band Ligation Plus Propranolol for the Prevention of Recurrent Esophageal Variceal Bleeding.
Topics: Adrenergic beta-Antagonists; Combined Modality Therapy; Endoscopy, Gastrointestinal; Esophageal and | 2015 |
Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gast | 2015 |
Equal efficacy of endoscopic variceal ligation and propranolol in preventing variceal bleeding in patients with noncirrhotic portal hypertension.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Child; Child, Preschool; Esophageal and Gastric Vari | 2010 |
Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Child; Cyanoacrylates; Embolization, Therapeut | 2010 |
Status of propranolol for treatment of infantile hemangioma and description of a randomized clinical trial.
Topics: Age Factors; Child; Child, Preschool; Hemangioma; Humans; Prednisolone; Propranolol; Recurrence; Tre | 2011 |
The study of antiarrhythmic medications in infancy (SAMIS): a multicenter, randomized controlled trial comparing the efficacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants.
Topics: Anti-Arrhythmia Agents; Canada; Chi-Square Distribution; Digoxin; Double-Blind Method; Female; Human | 2012 |
[New possibilities in the treatment of early stages of rosacea].
Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Anti-Bacterial Agents; Erythema; Female | 2013 |
Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients' well-being.
Topics: Adrenergic beta-Antagonists; Adult; Cross-Over Studies; Female; Follow-Up Studies; Humans; Male; Nad | 2002 |
Endoscopic histoacryl obliteration vs. propranolol in the prevention of esophagogastric variceal rebleeding: a randomized trial.
Topics: Adult; Aged; Antihypertensive Agents; Enbucrilate; Endoscopy; Esophageal and Gastric Varices; Female | 2003 |
Cirrhosis and bleeding: the need for very early management.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Ascites; Double-Blind Method; Esophageal and Gastric Varic | 2003 |
Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices.
Topics: Adrenergic beta-Antagonists; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hu | 2005 |
Endoscopic sclerotherapy of oesophageal varices due to hepatosplenic schistosomiasis. A randomized controlled trial evaluating the effect of adjuvant propranolol therapy.
Topics: Adolescent; Adult; Aged; Chemotherapy, Adjuvant; Esophageal and Gastric Varices; Female; Humans; Mal | 2005 |
Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study.
Topics: Adrenergic beta-Antagonists; Adult; Attitude to Health; Double-Blind Method; Female; Fluoxetine; Hum | 2006 |
Failure of propranolol to prevent tilt-evoked systemic vasodilatation, adrenaline release and neurocardiogenic syncope.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anthropometry; Cross-Over Studies; Double-Blind Meth | 2006 |
A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation.
Topics: Adrenergic beta-Antagonists; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Ligation; Liver | 2007 |
Propranolol in prevention of recurrent gastrointestinal bleeding in cirrhotic patients.
Topics: Clinical Trials as Topic; Esophageal and Gastric Varices; Humans; Liver Cirrhosis; Peptic Ulcer Hemo | 1981 |
Beta Blocker Heart Attack Trial: design features.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Clinical Trials as Topic; Death, Sudden; Double-Blind Meth | 1981 |
Forum: beta-adrenoreceptor blockade after acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Death, Sudden; Humans; Metoprolol; Myocardial | 1982 |
beta-Blockers and myocardial infarction.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden; Diuretic | 1982 |
Secondary prevention with beta-adrenoceptor blockers in post-myocardial infarction patients.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Double-Blind Method; Humans; Metoprolol; Myoc | 1982 |
The Beta-Blocker Heart Attack Trial in perspective.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sud | 1983 |
Prophylactic use of beta-adrenergic blockade in survivors of myocardial infarction.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Death, Sudden; Humans; Metoprolol; Myocardial | 1984 |
[Use of the new beta-adrenoblockader Corgard in ischemic heart disease and arterial hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Coronar | 1984 |
Statistical aspects of early termination in the beta-blocker heart attack trial.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Humans; Myocardial Infarction; Probability; P | 1984 |
Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research group.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Double-Blind Method; Follow-Up Studies; Human | 1984 |
Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Myoca | 1983 |
Beta-adrenoreceptor blocking agents. Their role in reducing chances of recurrent infarction and death.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Inf | 1983 |
A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Fo | 1983 |
Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis.
Topics: Adult; Aged; Clinical Trials as Topic; Esophageal and Gastric Varices; Female; Gastrointestinal Hemo | 1983 |
What to do about esophageal varices?
Topics: Clinical Trials as Topic; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Propr | 1983 |
Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia.
Topics: Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarct | 1980 |
Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study.
Topics: Administration, Oral; Adult; Aged; Clinical Trials as Topic; Esophageal and Gastric Varices; Female; | 1981 |
beta-Blockade and recurrent myocardial infarction.
Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Myocardial Infarction; Propranolol; Random Al | 1982 |
The Norwegian propranolol trial in selected patients.
Topics: Adult; Aged; Clinical Trials as Topic; Death, Sudden; Double-Blind Method; Humans; Middle Aged; Myoc | 1982 |
Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Esophageal and Gastric Varices; Gastrointestinal | 1995 |
Long-term follow-up after acute myocardial infarction in patients randomized to treatment with intravenous magnesium or intravenous propranolol in the acute phase.
Topics: Aged; Female; Follow-Up Studies; Heart Failure; Humans; Infusions, Intravenous; Magnesium Sulfate; M | 1994 |
Prevention of rebleeding from oesophageal varices: two-year follow up of a prospective controlled trial of propranolol in addition to sclerotherapy.
Topics: Adolescent; Adult; Aged; Blood Pressure; Combined Modality Therapy; Esophageal and Gastric Varices; | 1994 |
Has propranolol rendered sclerotherapy obsolete for poor risk alcoholic cirrhotic patients?
Topics: Combined Modality Therapy; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis, | 1994 |
Propranolol versus sclerotherapy in preventing variceal rebleeding: a randomized controlled trial.
Topics: Aged; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged | 1993 |
Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial.
Topics: Aged; Combined Modality Therapy; Endoscopy; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; | 1993 |
A prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy.
Topics: Administration, Oral; Adolescent; Adult; Combined Modality Therapy; Double-Blind Method; Endoscopy; | 1993 |
[Prevention of digestive hemorrhage recurrence in hepatic cirrhosis with propranolol. A 4 years' follow-up study].
Topics: Adult; Aged; Aged, 80 and over; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastroint | 1993 |
Prognostic significance of electrocardiographic persistent ST depression in patients with their first myocardial infarction in the placebo arm of the Beta-Blocker Heart Attack Trial.
Topics: Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Pl | 1993 |
Sclerotherapy versus sclerotherapy and propranolol in the prevention of rebleeding from oesophageal varices: a randomised study.
Topics: Adult; Aged; Antihypertensive Agents; Combined Modality Therapy; Esophageal and Gastric Varices; Fem | 1996 |
Prevention of recurrent esophageal bleeding and survival in patients with alcoholic cirrhosis: a randomized study.
Topics: Adult; Aged; Antihypertensive Agents; Esophageal and Gastric Varices; Female; Gastrointestinal Hemor | 1996 |
Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Embolization, Therapeutic; Endoscopy; Eso | 1997 |
Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding.
Topics: Adult; Aged; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; | 1997 |
[Evaluation of the effects of diverse therapeutic treatments versus no treatment of patients with neurocardiogenic syncope].
Topics: Adolescent; Adult; Aged; Etilefrine; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; | 1998 |
Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding.
Topics: Adrenergic beta-Antagonists; Adult; Endoscopy; Esophageal and Gastric Varices; Female; Gastrointesti | 1999 |
[A randomized controlled study of ligustrazine in combination with propranolol for prevention of recurrent esophageal varices bleeding].
Topics: Adult; Aged; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hem | 2000 |
Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding.
Topics: Adrenergic beta-Antagonists; Esophageal and Gastric Varices; Esophagoscopy; Follow-Up Studies; Gastr | 2000 |
Treating electrical storm : sympathetic blockade versus advanced cardiac life support-guided therapy.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Autonomic Nerve Block; Female; Follow-Up | 2000 |
The effects of endoscopic variceal ligation and propranolol on portal hypertensive gastropathy: a prospective, controlled trial.
Topics: Adult; Aged; Combined Modality Therapy; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; | 2001 |
Prophylaxis of migraine in children.
Topics: Adolescent; Child; Clinical Trials as Topic; Cyproheptadine; Humans; Migraine Disorders; Pizotyline; | 1977 |
Medical versus surgical therapy for acute coronary insufficiency. A randomized study.
Topics: Acute Disease; Adult; Angina Pectoris; Coronary Artery Bypass; Exercise Test; Follow-Up Studies; Hos | 1975 |
Antazoline therapy of recurrent refractory supraventricular arrhythmias--a preliminary report.
Topics: Adolescent; Adult; Aged; Antazoline; Arrhythmias, Cardiac; Chronic Disease; Clinical Trials as Topic | 1975 |
Does elective sclerotherapy improve the efficacy of long-term propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter, randomized trial.
Topics: Esophageal Diseases; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Liv | 1992 |
Endoscopic sclerotherapy versus propranolol in prevention of recurrent variceal bleeding in patients with child's B and C cirrhosis: a preliminary report.
Topics: Adult; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; | 1992 |
Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliteration.
Topics: Adult; Aged; Esophageal and Gastric Varices; Esophagoscopy; Female; Gastrointestinal Hemorrhage; Hum | 1992 |
Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis.
Topics: Actuarial Analysis; Acute Disease; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up | 1991 |
[Prevention of recurrent hemorrhage in patients with cirrhosis. Results of a controlled trial of propranolol versus endoscopic sclerotherapy].
Topics: Actuarial Analysis; Adult; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Foll | 1991 |
Propranolol in the management of recurrent migraine: a meta-analytic review.
Topics: Adult; Female; Humans; Male; Meta-Analysis as Topic; Migraine Disorders; Prognosis; Propranolol; Rec | 1991 |
[Prospective controlled study of elective sclerotherapy plus oral propranolol for prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage].
Topics: Administration, Oral; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatic Veins; Hu | 1991 |
Quality of life after bypass surgery for unstable angina. 5-year follow-up results of a Veterans Affairs Cooperative Study.
Topics: Angina, Unstable; Coronary Artery Bypass; Exercise Test; Follow-Up Studies; Humans; Male; Middle Age | 1991 |
Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapy.
Topics: Combined Modality Therapy; Esophageal and Gastric Varices; Follow-Up Studies; Gastrointestinal Hemor | 1991 |
Natural history of the first non-Q wave myocardial infarction in the placebo arm of the Beta-Blocker Heart Attack Trial.
Topics: Double-Blind Method; Electrocardiography; Follow-Up Studies; Humans; Myocardial Infarction; Placebos | 1991 |
Long-term pharmacologic therapy of portal hypertension.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Hemodynamics; Humans; Hypertension, Portal; M | 1990 |
Pharmacological versus non-pharmacological prophylaxis of recurrent migraine headache: a meta-analytic review of clinical trials.
Topics: Analysis of Variance; Biofeedback, Psychology; Humans; Meta-Analysis as Topic; Migraine Disorders; O | 1990 |
A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of variceal bleeding.
Topics: Administration, Oral; Blood Pressure; Clinical Trials as Topic; Esophageal and Gastric Varices; Fema | 1990 |
Prevention of recurrent variceal hemorrhage: to block or not to block?
Topics: Atenolol; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Prop | 1990 |
Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial.
Topics: Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Multicenter Studies as | 1990 |
Evaluation of propranolol for prevention of recurrent bleeding from esophageal varices between sclerotherapy sessions.
Topics: Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Prop | 1990 |
Efficacy of oral propranolol and injection sclerotherapy in the long-term management of variceal bleeding.
Topics: Administration, Oral; Adult; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hu | 1990 |
Propranolol may prevent recurrence of oesophageal varices after obliteration by endoscopic sclerotherapy.
Topics: Adult; Aged; Combined Modality Therapy; Double-Blind Method; Esophageal and Gastric Varices; Esophag | 1990 |
Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic patients. A controlled trial.
Topics: Double-Blind Method; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Li | 1990 |
Effects of cigarette smoking and propranolol in survivors of acute myocardial infarction.
Topics: Double-Blind Method; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Inf | 1990 |
Controlled trial of propranolol to prevent recurrent variceal bleeding in patients with non-cirrhotic portal fibrosis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Clinical Trials as Topic; Esophageal and Gastric Vari | 1989 |
[Prevention of recurrent hemorrhage caused by the rupture of esophageal varices in cirrhotic patients. A controlled study of propranolol and clip ligation of the esophagus].
Topics: Adult; Aged; Clinical Trials as Topic; Esophageal and Gastric Varices; Esophagus; Female; Gastrointe | 1989 |
Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial.
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Aged; Alcohol Drinking; Atenolol; Clinical Trials a | 1989 |
Propranolol in prevention of rebleeding from oesophageal varices during the course of endoscopic sclerotherapy.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Esophageal and Gastric Varices; Esophago | 1989 |
A randomised controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis.
Topics: Adult; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Male; Propranolol; Randomized C | 1989 |
Comparison of three nonsurgical treatments for bleeding esophageal varices.
Topics: Blood Transfusion; Combined Modality Therapy; Esophageal and Gastric Varices; Esophagoscopy; Ethanol | 1989 |
Sclerotherapy versus propranolol after first variceal haemorrhage in alcoholic cirrhosis.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis, Alcoholic; Pro | 1985 |
Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Cineangiography; Clinical Trials as Topic; Double-Blind Method; Female; | 1987 |
[Endoscopic sclerotherapy versus propranolol after hemorrhage caused by rupture of esophageal varices in patients with cirrhosis. Results of a 4-year randomized study].
Topics: Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Male; | 1988 |
Reduction in early recurrence of variceal bleeding by propranolol.
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Esophageal and Gastric Varices; Female; Gastro | 1988 |
Mortality in the beta blocker heart attack trial: circumstances surrounding death.
Topics: Aged; Cardiovascular Diseases; Clinical Trials as Topic; Death, Sudden; Double-Blind Method; Female; | 1987 |
[Controlled study of propranolol in the prevention of recurrent hemorrhage in cirrhotic patients].
Topics: Adult; Aged; Clinical Trials as Topic; Esophageal and Gastric Varices; Follow-Up Studies; Gastrointe | 1987 |
Ideal treatment of portal hypertension in 1985.
Topics: Acute Disease; Clinical Trials as Topic; Double-Blind Method; Endoscopy; Esophageal and Gastric Vari | 1985 |
Enhancement of visit adherence in the national beta-blocker heart attack trial.
Topics: Adult; Aged; Appointments and Schedules; Clinical Trials as Topic; Double-Blind Method; Humans; Midd | 1985 |
146 other studies available for propranolol and Recrudescence
| Article | Year |
|---|---|
Experience using propranolol for the management of supraventricular tachycardia in patients younger than 1 year.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Dose-Response Relationship, Drug; Electrocardiogr | 2020 |
Topical β-blockers for pyogenic granulomas: A promising option for younger patients.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Granuloma, Pyogenic; Humans; Propranolol; Recu | 2021 |
Preoperative and perioperative intervention reduces the risk of recurrence of endometriosis in mice caused by either incomplete excision or spillage and dissemination.
Topics: Animals; Aprepitant; Cell Proliferation; Combined Modality Therapy; Disease Models, Animal; Diterpen | 2021 |
Infantile hemangioma: factors causing recurrence after propranolol treatment.
Topics: Biomarkers; Female; Hemangioma; Hemodynamics; Humans; Infant; Infant, Newborn; Male; MicroRNAs; Prop | 2018 |
Recurrent hypoglycaemia in a toddler on β-blocker therapy.
Topics: Adrenergic beta-Antagonists; Blood Glucose; Child, Preschool; Female; Humans; Hypoglycemia; Ketosis; | 2018 |
Noradrenergic β-receptor antagonism in the basolateral amygdala impairs reconsolidation, but not extinction, of alcohol self-administration: Intra-BLA propranolol impairs reconsolidation of alcohol self-administration.
Topics: Adrenergic beta-Antagonists; Alcoholism; Animals; Basolateral Nuclear Complex; Conditioning, Operant | 2018 |
Recurrent parotid cavernous haemangioma in an adolescent, successfully treated with Propranolol.
Topics: Adolescent; Hemangioma, Cavernous; Humans; Male; Parotid Neoplasms; Propranolol; Recurrence; Vasodil | 2018 |
Transjugular intrahepatic portosystemic shunt prevents rebleeding in cirrhotic patients having cavernous transformation of the portal vein without improving their survival.
Topics: Adult; Aged; Antihypertensive Agents; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gas | 2019 |
Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Case-Control Studies; Female; Hemodynam | 2013 |
Annular telangiectatic perivascular angiomatosis: a paradoxical adverse event of propranolol.
Topics: Aged, 80 and over; Angiomatosis; Antihypertensive Agents; Female; Humans; Hypertension; Propranolol; | 2013 |
Retrospective analysis of beta-blocker instituted for treatment of hemangiomas (RABBIT study).
Topics: Administration, Oral; Adrenergic beta-Antagonists; Female; Follow-Up Studies; Hemangioma; Humans; In | 2014 |
Efficacy and safety of high-dose propranolol for the management of infant supraventricular tachyarrhythmias.
Topics: Anti-Arrhythmia Agents; Female; Humans; Infant; Infant, Newborn; Male; Propranolol; Recurrence; Retr | 2015 |
Oral propranolol and intravitreal ranibizumab for refractory serous macular detachment secondary to retinal capillary hemangioblastoma.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Angiogenesis Inhibitors; Combined Modality | 2015 |
Delayed-onset of multiple cutaneous infantile hemangiomas due to propranolol: a case report.
Topics: Dose-Response Relationship, Drug; Heart Defects, Congenital; Hemangioma; Humans; Infant; Infant, New | 2015 |
Effect of Selective Inhibition of Reactivated Nicotine-Associated Memories With Propranolol on Nicotine Craving.
Topics: Adolescent; Adult; Animals; Association Learning; Conditioning, Classical; Craving; Female; Humans; | 2017 |
Thyrotoxic hypokalemic periodic paralysis as the presenting symptom in a young Ashkenazi Jewish man.
Topics: Adult; Antihypertensive Agents; Antithyroid Agents; Emergencies; Follow-Up Studies; Genetic Predispo | 2009 |
Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: A preliminary retrospective study of French experience.
Topics: Adrenergic beta-Antagonists; Airway Obstruction; Drug Resistance; Hemangioma; Humans; Infant; Infant | 2010 |
[Update on current care guidelines; childhood headache].
Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Child; Headache; Humans; Ibuprofen; Propranolol | 2010 |
Initial experience using propranolol as an adjunctive treatment in children with aggressive recurrent respiratory papillomatosis.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Dysphonia; Female; Humans; Laryngeal Neop | 2011 |
Expanding our therapeutic options: Beta blockers for breast cancer?
Topics: Adrenergic beta-Antagonists; Atenolol; Breast Neoplasms; Diabetes Complications; Disease-Free Surviv | 2011 |
Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Cost-Benefit Analysis; Female; Glucocorticoids; H | 2011 |
Intraosseous infusion is unreliable for adenosine delivery in the treatment of supraventricular tachycardia.
Topics: Adenosine; Amiodarone; Catheterization, Central Venous; Combined Modality Therapy; Drug Therapy, Com | 2012 |
Differential effect of beta-adrenergic receptor antagonism in basolateral amygdala on reconsolidation of aversive and appetitive memories associated with morphine in rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amygdala; Analysis of Variance; Animals; | 2014 |
[Recurrent gelastic syncopes].
Topics: Aged; Epilepsies, Partial; Humans; Laughter; Male; Propranolol; Recurrence; Syncope | 2012 |
Endoscopic and pharmacological secondary prophylaxis in children and adolescents with esophageal varices.
Topics: Adolescent; Adrenergic beta-Antagonists; Child; Child, Preschool; Endoscopy, Gastrointestinal; Esoph | 2013 |
Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Female; Hemangioma; Humans; Infant; Male; Photogr | 2012 |
Recurrent bleeding in an 18-year-old girl.
Topics: Adolescent; Female; Hemorrhage; Humans; Propranolol; Recurrence; Skin Diseases; Stress, Physiologica | 2012 |
Alpha(1)-adrenoceptor stimulation directly induces growth of vascular wall in vivo.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; | 2002 |
Propranolol for reemergent posttraumatic stress disorder following an event of retraumatization: a case study.
Topics: Accidents, Traffic; Adult; Anti-Anxiety Agents; Female; Humans; Propranolol; Recurrence; Stress Diso | 2002 |
Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.
Topics: Antihypertensive Agents; Ascites; Bacterial Infections; Cohort Studies; Drug Therapy, Combination; F | 2003 |
Comparison of frequency of recurrent syncope after beta-blocker therapy versus conservative management for patients with vasovagal syncope.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Comorbidity; Female; Humans; Male; Metoprolol; M | 2003 |
Long-term outcome after sclerotherapy with or without a beta-blocker for variceal bleeding in children.
Topics: Antihypertensive Agents; Child; Child, Preschool; Combined Modality Therapy; Esophageal and Gastric | 2003 |
Frequency of recurrence among infants with supraventricular tachycardia and comparison of recurrence rates among those with and without preexcitation and among those with and without response to digoxin and/or propranolol therapy.
Topics: Age of Onset; Anti-Arrhythmia Agents; Digoxin; Female; Heart Defects, Congenital; Humans; Infant; In | 2003 |
Treatment of recurrent gastrointestinal haemorrhage in a patient with von Willebrand's disease with octreotide LAR and propranolol.
Topics: Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Octreotide; Propr | 2005 |
Suppression by propranolol and amiodarone of an electrical storm refractory to metoprolol and amiodarone.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Defibrillator | 2005 |
Thyrotoxic periodic paralysis in a Turkish male; the recurrence of the attack after radioiodine treatment.
Topics: Adrenergic beta-Antagonists; Adult; Humans; Hyperthyroidism; Hypokalemia; Iodine Radioisotopes; Male | 2005 |
Primary prophylaxis against variceal bleeding: beta-blockers, endoscopic ligation, or both?
Topics: Adrenergic beta-Antagonists; Combined Modality Therapy; Esophageal and Gastric Varices; Esophagoscop | 2005 |
Recurrent cardiogenic shock caused by dynamic mitral regurgitation in a patient with hypertrophic obstructive cardiomyopathy: a case report.
Topics: Adrenergic beta-Antagonists; Aged; Cardiomyopathy, Hypertrophic; Combined Modality Therapy; Heart Va | 2005 |
Effects of therapy based on tilt testing results on the long-term outcome in patients with syncope.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Female; Fludroco | 2005 |
[Hemodynamic response to a single dose of intravenous propranolol in the prophylaxis of variceal bleeding].
Topics: Administration, Oral; Adrenergic beta-Antagonists; Blood Pressure; Drug Evaluation; Esophageal and G | 2005 |
[Cyclic vomiting in children].
Topics: Adolescent; Adrenergic beta-Antagonists; Child; Female; Fluid Therapy; Humans; Periodicity; Proprano | 2006 |
The use of propranolol to treat central serous chorioretinopathy: an evaluation by serial OCT.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Choroid Diseases; Female; Humans; Proprano | 2006 |
Macroscopic T wave alternans in long QT syndrome.
Topics: Anti-Arrhythmia Agents; Child; Electrocardiography; Female; Humans; Long QT Syndrome; Propranolol; R | 2006 |
A case of neurally mediated syncope induced by laughter successfully treated with combination of propranolol and midodrine.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Aged; Drug Therapy, Combination; Electrocard | 2007 |
Clinical trials for variceal bleeding: and the winner is--the patient.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Gastrointestinal Hemorrhage; Humans; Liver Tr | 2007 |
The beta-blocker heart attack trial.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Humans; Myocardial Infarction; Propranolol; R | 1982 |
Nadolol and supraventricular tachycardia: an electrophysiologic study.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Atrioventricular Node; | 1983 |
[Secondary prevention of myocardial infarct with beta blockers].
Topics: Adrenergic beta-Antagonists; Coronary Circulation; Coronary Disease; Humans; Metoprolol; Myocardial | 1983 |
Recurrent bleeding and propranolol?
Topics: Carcinoma, Hepatocellular; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Live | 1983 |
[Therapy of bleeding esophageal varices].
Topics: Embolization, Therapeutic; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Port | 1984 |
Propranolol does not further decrease the clearance of antipyrine in patients with alcoholic cirrhosis.
Topics: Adult; Antipyrine; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis, Alcoholic; Male; Metabolic | 1983 |
[Functional autonomic blockade in the diagnosis of functional sinus node disorders].
Topics: Adolescent; Adult; Aged; Atropine; Autonomic Nerve Block; Cardiac Catheterization; Electrocardiograp | 1984 |
[1st attempt at using the antioxidant dibunol in the acute stage of a myocardial infarct].
Topics: Acute Disease; Adult; Aged; Antioxidants; Butylated Hydroxytoluene; Drug Therapy, Combination; Femal | 1984 |
Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest.
Topics: Adult; Aged; Death, Sudden; Electrophysiology; Female; Heart Arrest; Humans; Male; Middle Aged; Pati | 1983 |
[Medical treatment of hemorrhage in portal hypertension of the cirrhotic patient using propanolol].
Topics: Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Propranolol; Recurrence | 1982 |
Injection sclerotherapy of esophageal varices.
Topics: Endoscopy; Esophageal and Gastric Varices; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; L | 1982 |
Propranolol for gastrointestinal bleeding in cirrhosis.
Topics: Administration, Oral; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cir | 1982 |
Endomyocardial resection for recurrent ventricular tachycardia. Report of a case.
Topics: Adult; Electrocardiography; Endocardium; Humans; Lidocaine; Male; Procaine; Propranolol; Recurrence; | 1982 |
Efficacy of nifedipine in rest angina refractory to propranolol and nitrates in patients with obstructive coronary artery disease.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged | 1981 |
Ventricular ectopic activity after medical and surgical treatment for recurrent sustained ventricular tachycardia.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Fe | 1980 |
Compulsive water drinking treated with high dose propranolol.
Topics: Adult; Compulsive Behavior; Drinking; Female; Humans; Propranolol; Recurrence; Schizophrenia, Parano | 1980 |
Recurrent postpartum painless thyroiditis.
Topics: Adult; Female; Humans; Iodine Radioisotopes; Pain; Pregnancy; Propranolol; Puerperal Disorders; Recu | 1980 |
Intravenous propranolol therapy for acute myocardial infarction in man: hemodynamic and serial creatine kinase assessment.
Topics: Adult; Aged; Creatine Kinase; Female; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Ag | 1981 |
[Beta-receptor blockers after revascularization in coronary sclerosis].
Topics: Adrenergic beta-Antagonists; Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Diseas | 1995 |
[Endoscopic sclerotherapy: does propranolol reduce the risk of hemorrhagic recurrence?].
Topics: Combined Modality Therapy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Live | 1994 |
[Hyperthyroidism at elevated thyreostimulin. A case with pituitary resistance to thyroid hormones].
Topics: Adult; Drug Therapy, Combination; Humans; Hyperthyroidism; Male; Pituitary Diseases; Propranolol; Re | 1994 |
[The effect of calcium antagonists and beta-adrenoblockaders on disordered stomach functions in patients with duodenal peptic ulcer].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Calcium Channel Blockers; Drug Evaluation; Duodenal | 1994 |
[Nasal polyps and chronic sinusitis as a possible adverse effect of non-selective beta blockers].
Topics: Adrenergic beta-Antagonists; Aged; Chronic Disease; Female; Humans; Male; Nasal Polyps; Propranolol; | 1994 |
Relapse of medically treated insulinoma following the development of thyrotoxicosis: an assessment of potential mechanisms.
Topics: Aged; C-Peptide; Diazoxide; Female; Humans; Hypoglycemia; Insulin; Insulin Resistance; Insulinoma; P | 1994 |
Occupational contact dermatitis from propranolol.
Topics: Dermatitis, Allergic Contact; Dermatitis, Occupational; Drug Industry; Humans; Male; Middle Aged; Pr | 1994 |
[Carotid sinus massage in diagnosing syncope of unknown origin].
Topics: Adult; Aged; Female; Heart Massage; Humans; Male; Middle Aged; Posture; Propranolol; Recurrence; Syn | 1993 |
Recurrent migraine and intravenous immune globulin therapy.
Topics: Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Migraine Disorders; Polyradiculoneuropathy; | 1993 |
Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants.
Topics: Anti-Arrhythmia Agents; Catheter Ablation; Digoxin; Electrocardiography; Esophagus; Female; Follow-U | 1996 |
Propranolol suppression of ocular HSV-1 recurrence and associated corneal lesions following spontaneous reactivation in the rabbit.
Topics: Adrenergic beta-Antagonists; Animals; Cornea; Epithelium; Female; Keratitis, Herpetic; Male; Mice; P | 1996 |
The hepatic venous pressure gradient: has the time arrived for its application in clinical practice?
Topics: Clinical Trials as Topic; Hemorrhage; Hepatic Veins; Humans; Liver Cirrhosis; Propranolol; Prospecti | 1996 |
Neonatal supraventricular tachycardia: predictors of successful treatment withdrawal.
Topics: Anti-Arrhythmia Agents; Digoxin; Electrocardiography; Esophagus; Follow-Up Studies; Humans; Infant, | 1997 |
TIPSS trials: design determines outcome.
Topics: Clinical Trials as Topic; Endoscopy; Esophageal and Gastric Varices; Esophageal Diseases; Hemorrhage | 1997 |
Long-term treatment of bleeding caused by portal hypertension in children.
Topics: Administration, Oral; Adult; Child; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal | 1997 |
Clinical vs haemodynamic response to drugs in portal hypertension.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Esophageal and Gastric Varices; Female; Follow-Up Studi | 1998 |
Abdominal migraine: prophylactic treatment and follow-up.
Topics: Abdominal Pain; Adolescent; Child; Child, Preschool; Cyproheptadine; Female; Gastrointestinal Agents | 1999 |
Normokalemic thyrotoxic periodic paralysis: a new therapeutic strategy.
Topics: Adult; Drug Therapy, Combination; Humans; Male; Methimazole; Paralysis; Potassium; Prednisone; Propr | 1999 |
[Chronic recurrent headache without neurological abnormalities. Practice guidelines of the Netherlands Society of Neurology].
Topics: Adult; Aged; Chronic Disease; Contraindications; Drug Interactions; Female; Guidelines as Topic; Hea | 1999 |
Hepatorenal syndrome in cirrhotic patients: terlipressine is a safe and efficient treatment; propranolol and digitalic treatments: precipitating and preventing factors?
Topics: Adult; Aged; Digitoxin; Female; Hepatorenal Syndrome; Humans; Kidney Function Tests; Liver Cirrhosis | 2000 |
[Thyrotoxic periodic paralysis--an unusual complication of hyperthyroidism].
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Carbimazole; Electrocardiography; Female; Gr | 2002 |
Editorial: Beta adrenergic blockade for prophylaxis against recurrent myocardial infarction and sudden death.
Topics: Adrenergic beta-Antagonists; Coronary Disease; Death, Sudden; Humans; Myocardial Infarction; Practol | 1976 |
[Effect of beta blockaders in the prevention of recurrent ventricular tachycardia].
Topics: Adrenergic beta-Antagonists; Humans; Propranolol; Recurrence; Tachycardia | 1978 |
Cardiac pacing and pacemakers II. Serial electrophysiologic-pharmacologic testing for control of recurrent tachyarrhythmias.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Bretylium Compounds; Cardiac Complexes, Premature; | 1977 |
Basis for recurring ventricular fibrillation in the absence of coronary heart disease and its management.
Topics: Adult; Anti-Arrhythmia Agents; Coronary Disease; Digitalis Glycosides; Drug Therapy, Combination; El | 1976 |
Delayed semielective coronary bypass surgery for unstable angina pectoris: clinical follow-up and results of postoperative treadmill exercise.
Topics: Angina Pectoris; Coronary Artery Bypass; Follow-Up Studies; Heart Function Tests; Humans; Middle Age | 1978 |
Clinical predictors of angina following myocardial infarction.
Topics: Acute Disease; Aged; Angina Pectoris; Coronary Artery Bypass; Exercise Test; Female; Follow-Up Studi | 1979 |
[Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis].
Topics: Adult; Aldosterone; Bartter Syndrome; Depression, Chemical; Female; Humans; Hyperaldosteronism; Indo | 1979 |
Chronic recurrent angina.
Topics: Angina Pectoris; Angina Pectoris, Variant; Chronic Disease; Electrocardiography; Follow-Up Studies; | 1979 |
Use of isoproterenol as an aid to electric induction of chronic recurrent ventricular tachycardia.
Topics: Adolescent; Adult; Aged; Chronic Disease; Electric Stimulation; Exercise Test; Female; Heart Rate; H | 1979 |
[Recurrent polyradiculoneuritis. Possible role of carbimazole].
Topics: Aged; Carbimazole; Drug Therapy, Combination; Female; Graves Disease; Humans; Polyradiculoneuropathy | 1979 |
Blood pressure rebound following withdrawal of antihypertensive treatment.
Topics: Blood Pressure; Clonidine; Humans; Hypertension, Renal; Propranolol; Recurrence; Substance Withdrawa | 1978 |
Mitral-valve prolapse syndrome and recurrent ventricular tachyarrhythmias: a malignant variant refractory to conventional drug therapy.
Topics: Adult; Aged; Aprindine; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Male; Middle Aged | 1978 |
Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; D | 1978 |
Sudden withdrawal of propranolol in patients with angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Cardiovascular Diseases; Coronary Disease; Female; Humans; Male; Middl | 1977 |
Resistant ventricular tachycardias and recurrent cardiac arrests. 96 episodes.
Topics: Aged; Disopyramide; Electric Countershock; Heart Aneurysm; Humans; Male; Myocardial Infarction; Prop | 1977 |
Treatment of recurrent symptomatic ventricular tachycardia.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiomyopathies; Coronary Disease; Drug Evaluation; Female; He | 1976 |
Patient-initiated rapid atrial pacing to manage supraventricular tachycardia.
Topics: Adult; Aged; Atrial Fibrillation; Digoxin; Heart Rate; Humans; Male; Middle Aged; Pacemaker, Artific | 1976 |
Homotransplant renal artery stenosis.
Topics: Angiography; Benzothiadiazines; Child; Guanethidine; Humans; Hydralazine; Hypertension, Renal; Kidne | 1975 |
Idiopathic paroxysmal ventricular tachycardia in infants and children.
Topics: Adolescent; Arrhythmias, Cardiac; Child; Child, Preschool; Drug Therapy, Combination; Electrocardiog | 1975 |
[The effect of propranolol, lisinopril, prednisolone, colchicine, etoposide and vincristine on proliferation of re-stenosing human plaque cells in vitro: cell culture as a prescreening system for prevention of restenosis].
Topics: Angioplasty, Balloon; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Atherectomy; Cell | 1992 |
Propranolol for portal hypertensive gastropathy: another virtue of beta-blockade?
Topics: Adrenergic beta-Antagonists; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrho | 1992 |
Cessation of recurrent bleeding from gastrointestinal angiodysplasia, after beta blocker treatment in a patient with hypertrophic subaortic stenosis--a case history.
Topics: Aged; Angiodysplasia; Cardiomyopathy, Hypertrophic; Cecal Diseases; Combined Modality Therapy; Femal | 1992 |
[Adrenergic beta blockade in liver cirrhosis with portal hypertension? Doppler ultrasound measurement of the short-term effect of propranolol on the portal system].
Topics: Blood Flow Velocity; Esophageal and Gastric Varices; Follow-Up Studies; Gastrointestinal Hemorrhage; | 1992 |
Beta-adrenergic receptor activity in ponies with recurrent obstructive pulmonary disease.
Topics: Aerosols; Animals; Atenolol; Butoxamine; Histamine; Horse Diseases; Horses; Isoproterenol; Lung Dise | 1991 |
The child with recurrent syncope: autonomic function testing and beta-adrenergic hypersensitivity.
Topics: Adolescent; Adrenergic beta-Antagonists; Atenolol; Autonomic Nervous System; Child; Epinephrine; Fem | 1991 |
Recurrence of 131I-induced thyroid storm after discontinuing glucocorticoid therapy.
Topics: Adult; Dexamethasone; Drug Therapy, Combination; Female; Humans; Infant; Iodine Radioisotopes; Propr | 1991 |
Relapsing anaphylaxis to bee sting in a patient treated with beta-blocker and Ca blocker.
Topics: Anaphylaxis; Animals; Bees; Drug Therapy, Combination; Humans; Insect Bites and Stings; Male; Middle | 1990 |
Propranolol-induced reduction in recurrent variceal hemorrhage in schistosomiasis.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Propranolol; Recurrence; Schist | 1990 |
[The use of labetalol and propranolol in patients who have had a myocardial infarct].
Topics: Adult; Drug Evaluation; Exercise Test; Humans; Labetalol; Middle Aged; Myocardial Infarction; Physic | 1990 |
Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT Study).
Topics: Adult; Aged; Death, Sudden; Double-Blind Method; Humans; Middle Aged; Myocardial Infarction; Posture | 1989 |
Exercise training after experimental myocardial infarction increases the ventricular fibrillation threshold before and after the onset of reinfarction in the isolated rat heart.
Topics: Animals; Coronary Disease; Differential Threshold; Epinephrine; In Vitro Techniques; Male; Myocardia | 1989 |
Prophylaxis against repeated radiocontrast media reactions in 857 cases. Adverse experience with cimetidine and safety of beta-adrenergic antagonists.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anaphylaxis; Cimetidine; Contrast Media; Diphenhydra | 1985 |
Beta-blocker therapy after myocardial infarction: secondary prevention in all patients?
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Electrocardiography; Exercise Test; Heart; Humans | 1985 |
[Beta-blockers and digestive hemorrhages].
Topics: Adrenergic beta-Antagonists; Digestive System Diseases; Hemorrhage; Humans; Propranolol; Recurrence | 1987 |
[Severe periodic hypokalemic paralysis. Prevention using beta-receptor blockade].
Topics: Adrenergic beta-Antagonists; Adult; Dietary Carbohydrates; Humans; Hypokalemia; Male; Paralysis; Phy | 1987 |
[Prevention of hemorrhagic recurrence in Child's group A cirrhotic patients].
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Portacaval Shu | 1987 |
[Prevention of hemorrhagic recurrence in cirrhotic patients. Is sclerotherapy better than propranolol?].
Topics: Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Male; | 1988 |
[A case of recurrent myocardial infarction after discontinuation of the treatment with beta adrenergic receptor blockaders].
Topics: Humans; Male; Middle Aged; Myocardial Infarction; Propranolol; Recurrence | 1988 |
Effects of beta-adrenergic stimulation on atrial latency and atrial vulnerability in patients with paroxysmal supraventricular tachycardia.
Topics: Adult; Aged; Cardiac Pacing, Artificial; Drug Evaluation; Female; Heart Atria; Heart Conduction Syst | 1988 |
[Prevention of recurrent hemorrhage due to portal hypertension].
Topics: Double-Blind Method; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Hum | 1986 |
Emergency portacaval shunt for variceal hemorrhage. A prospective study.
Topics: Emergencies; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Middle Aged; Porta | 1987 |
Comparative study between propranolol and sclerotherapy in prophylactic treatment of oesophageal varices and prevention of recurrent bleeding attacks.
Topics: Adult; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Propr | 1987 |
Thyrotoxic periodic paralysis with relapse during the euthyroid state.
Topics: Adult; Humans; Hypokalemia; Male; Methimazole; Paralysis; Periodicity; Propranolol; Recurrence; Thyr | 1987 |
The long-term outcome of patients who suffered and survived an acute myocardial infarction in the midst of recurrent attacks of variant angina.
Topics: Angina Pectoris, Variant; Cardiac Catheterization; Drug Therapy, Combination; Electrocardiography; F | 1986 |
Atrioventricular pacemaker placement in Romano-Ward syndrome and recurrent torsades de pointes.
Topics: Adult; Arrhythmias, Cardiac; Female; Humans; Long QT Syndrome; Pacemaker, Artificial; Propranolol; R | 1987 |
[Propranolol prevention of hemorrhagic recurrence caused by rupture of esophageal varices: worsened prognosis in ascites and jaundice].
Topics: Ascites; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Jaundice; Live | 1985 |
Thyrotoxic periodic paralysis.
Topics: Adult; Calcium; Hispanic or Latino; Humans; Hyperthyroidism; Iodine Radioisotopes; Male; Paralysis; | 1986 |
Ventricular tachydysrhythmias in near-miss sudden infant death syndrome.
Topics: Amiodarone; Heart Ventricles; Humans; Infant, Newborn; Infusions, Parenteral; Male; Procainamide; Pr | 1986 |
Variceal bleeding from an ileostomy stoma.
Topics: Hemorrhage; Humans; Hypertension, Portal; Ileostomy; Ileum; Ligation; Male; Middle Aged; Propranolol | 1985 |
[The effect of propranolol on portal hypertension in patients with varices after esophageal transection].
Topics: Esophageal and Gastric Varices; Esophagus; Hemodynamics; Humans; Hypertension, Portal; Postoperative | 1985 |
Non-synchronous elective cardioversion of chronic atrial arrhythmias.
Topics: Adolescent; Adult; Atrial Fibrillation; Cardiomegaly; Electric Countershock; Female; Humans; Male; M | 1972 |
Propranolol and cardioversion.
Topics: Adolescent; Adult; Atrial Fibrillation; Electric Countershock; Female; Humans; Male; Middle Aged; Mi | 1972 |
Migraine headaches.
Topics: Caffeine; Contraceptives, Oral; Cyproheptadine; Diagnosis, Differential; Diuretics; Drug Combination | 1972 |
Paroxysmal tachycardia in infancy: follow-up study of 47 subjects ranging in age from 10 to 26 years.
Topics: Adolescent; Adult; Age Factors; Angiocardiography; Body Height; Body Weight; Child; Digitalis; Elect | 1973 |
Paroxysmal tachycardia in infancy and childhood. II. Paroxysmal ventricular tachycardia and fibrillation.
Topics: Cardiomyopathies; Child; Child, Preschool; Digoxin; Electrocardiography; Female; Follow-Up Studies; | 1973 |
Electrocardiographic and clinical observations of a recurrent tachyarrhythmia arising from a pacemaker within the distribution of the anterior fascicle.
Topics: Bundle-Branch Block; Digitalis; Electric Countershock; Electrocardiography; Heart Atria; Heart Condu | 1974 |
Treatment of recurrent arrhythmia in a two year old child.
Topics: Child, Preschool; Electrocardiography; Female; Humans; Lidocaine; Propranolol; Recurrence; Tachycard | 1972 |
[2 cases of recurrent paroxysmal tachycardia treated with propranolol in infants].
Topics: Humans; Infant; Infant, Newborn; Male; Propranolol; Recurrence; Tachycardia, Paroxysmal | 1972 |
Propranolol and cluster headache.
Topics: Adult; Headache; Histamine; Humans; Male; Propranolol; Recurrence | 1972 |
Maintenance of sinus rhythm after atrial defibrillation.
Topics: Atrial Fibrillation; Delayed-Action Preparations; Drug Therapy, Combination; Electric Countershock; | 1970 |
Bretylium tosylate in the management of refractory ventricular fibrillation.
Topics: Adult; Age Factors; Aged; Angina Pectoris; Aortic Valve Insufficiency; Aortic Valve Stenosis; Bretyl | 1971 |
The management of recurrent thyrotoxicosis after thyroidectomy.
Topics: Carbimazole; Female; Humans; Hyperthyroidism; Iodine Isotopes; Male; Propranolol; Recurrence; Thyroi | 1971 |